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Since their discovery in the 1950s, polyene macrolides have been invaluable for treating 
life threatening fungal infections. Polyene antibiotics are unique because they target 
ergosterol, the fungal sterol, and disrupt the cellular processes that rely on ergosterol to 
function. While drug resistance threatens the utility of all other antifungal drug classes, 
polyene resistant strains remain rare. However, the polyene antibiotics in use have 
severe, dose-limiting side effects, and survival rates for systemic fungal infections are 
low. New compounds with improved therapeutic efficacy are needed.  
Polyene macrolides are produced by the soil bacteria Streptomyces. Streptomyces have 
an extensive and carefully regulated secondary metabolism which enables them to 
outcompete co-inhabiting microorganisms by producing antibiotics suited for the 
present stressor. Over two-thirds of the clinical antibiotics derived from a natural source 
are produced by Streptomyces, but there has been a marked regression in compound 
discovery in recent decades. The standardized use of cell monoculture techniques could 
be why the full production potential of Streptomyces is not met in a laboratory setting.  
In the current work, four strains of Streptomyces were cultured with baker’s yeast 
Saccharomyces cerevisiae to elicit the production of secondary metabolites that are not 
observed in monoculture conditions. One strain produced undecylprodigiosin and a 
cyclized derivative, but the other three strains produced significant amounts of 
unidentified polyene macrolides in co-culture conditions. Extracts from the 
Streptomyces were tested for bioactivity against yeast and analyzed with high pressure 
liquid chromatography, mass spectrometry and nuclear magnetic resonance.  
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1 Literature Review 
1.1 Streptomyces: Natural Chemists 
Streptomyces is a genus of mycelial, soil-dwelling actinobacteria that is best known for 
producing a diverse abundance of biologically active metabolites. Compounds produced 
by Streptomyces include hydrolytic exoenzymes and an array of structurally complex 
antibiotics. Hydrolytic exoenzymes facilitate decomposition in soil by freeing carbon 
from organic debris that cannot dissolve in water. The digested debris from plant 
cellulose and fungal chitin then serve as nutrient sources for Streptomyces and other 
competing microbes in the microenvironment. (Barka et al., 2016) When nutrients 
become limited, antibiotics are produced to give a competitive advantage over 
neighboring species (Netzker et al., 2018). As soil nutrients deplete, mycelial structures 
lyse to release the intracellular nutrients needed to produce spores. Streptomyces will 
remain dormant in spores until growth conditions improve. To protect the nutrients 
released from lysed mycelial cells during sporulation, antibiotics are essential. (Traxler 
& Roberto, 2015) 
The antibiotics produced by Streptomyces belong to a class of metabolic products 
known as secondary metabolites; these compounds are not required for cells to develop 
and reproduce (Scherlach et al., 2013). Secondary metabolites improve survivability of 
Streptomyces, and a vast amount have been developed as anticancer drugs, antifungal 
drugs, pesticides and clinical antibiotics for human use (Medema et al., 2014). Two-
thirds of all naturally derived antibiotics in use have been developed from Streptomyces 
(Barka et al., 2016). However, the full production potential of secondary metabolites is 
not reached when Streptomyces are grown under standard laboratory conditions. 
Genome sequencing reveals a multitude of biosynthetic gene clusters (BGC) that remain 
silent in laboratory cultivations. (Wezel & McDowall, 2011) 
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For decades, Streptomyces coelicolor has served as a model species for studying 
antibiotic biosynthesis and regulation, and it was revered for producing four clinically 
significant antibiotics (Challis, 2014). The true production potential of S. coelicolor was 
first noticed in 2002 when the full genome sequence was published, and 7,825 genes 
were predicted. The genome contains more than 20 BGCs which encode the enzymes 
needed to synthesize as many individual secondary metabolites. The sequence also 
predicted 965 regulatory proteins and 65 sigma factors responsible for controlling 
secondary metabolite biosynthesis. (Bentley et al., 2002) Further genome analysis of 
other species of Streptomyces has revealed even greater potential; some species could 
produce more than 50 different secondary metabolites if they are grown in suitable 
conditions. (van der Meij et al., 2017) 
1.2 Polyene Macrolides, Generally 
Polyene macrolides are a class of bioactive polyketides primarily produced by 
streptomycetes and other actinobacteria (Caffrey et al., 2016). These compounds have 
between 20 and 40 carbons and contain three distinct chemical regions on a 
macrolactone ring. All polyene macrolides have a polar polyhydroxylated region and a 
strongly non-polar chromophore region containing three to eight carbon—carbon double 
bonds in conjugation. Many polyenes have a deoxy amino sugar residue attached by a 
glycosidic bond, as well as various carbonyl and hemiketal domains on the macrocyclic 
structure. The deoxyaminosugar and a carboxylic acid group make up the polar head of 
these compounds. (Kong et al., 2013) 
1.2.1 Polyene Biosynthesis 
The biosynthesis of all polyenes follows a similar scheme (Figure 1). The backbone of 
the macrolactone aglycone is assembled by modular type 1 polyketide synthase (t1PKS) 
enzymes composed of distinct domains. The acyl transferase domain selectively binds 
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small carboxylic acid units and transfers them to the ketosynthase domain. 
Decarboxylative condensation reactions add the building blocks to the growing chain 
that is held to the PKS enzyme by an acyl carrier protein. The selectivity of the acyl 
transferase for chain building units provides a factor of structural diversity between 
PKSs. The possible presence of ketoreductase, dehydratase or enoyl reductase modules 
in the PKS creates further diversity. An absence of these domains results in a fully 
oxidized ketones in the chain, whereas activity of all three results in the fully reduced 
saturated bonds. Hydroxyl groups and double bonds are formed in the presence of 
ketoreductase and ketoreductase with dehydratase, respectively. (Hopwood, 1997; 
Zotchev, 2003; Kong et al., 2013) 
"  
Figure 1: The biosynthesis of nystatin (Kong et al., 2013). 
Ultimately, the chain is cleaved from the acyl carrier protein, and a thioesterase domain 
cyclizes the chain. After the cyclization, a glycosyltransferase adds a sugar residue to the 
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first carbon after the chromophore region. An exocyclic methyl group on the fourth 
carbon after the chromophore is oxidized to a carboxyl group by cytochrome P450. The 
exocyclic carboxyl group and amino sugar are invaluable to the antifungal activity of 
polyenes, and positioning relative to the chromophore is largely conserved. (Aparicio et 
al., 2003) Some polyenes may undergo additional glycosylation reactions, or the 
exocyclic carboxyl group may convert to a carboxamide. The polyol chain can be 
further modified by cytochrome P450 to add more hydroxyl groups, or a hemiketal ring 
may form through the action of additional monooxygenases. The breadth of the 
structural diversity of polyenes grows as they continue to be studied. (Caffrey et al., 
2016; Low et al., 2018) 
1.2.2 Classifications and Properties of Polyene Macrolides 
Polyenes are classified as glycosylated or non-glycosylated, based on the presence of a 
sugar residue, and as trienes, tetraenes, pentaenes, hexaenes, heptaenes or octaenes, 
depending on the size of the chromophore. Compounds that have sp3 hybridized carbons 
within the chromophore are termed “degenerated,” since the conjugated system is 
disrupted by saturated bonds. (Zotchev, 2003) Degenerated polyenes have slightly lower 
antifungal activity than polyenes with intact chromophores. (Aszalos et al., 1985) The 
conjugated system of the chromophore distinguishes polyenes from other classes of 
macrolides and attributes identifying chemical properties. (Zotchev, 2003) 
The uv/vis absorption spectra of polyenes have three distinct peaks that shift to longer 
wavelengths as the size of the chromophore increases (Figure 2). For example, the 
tetraenes, nystatin and natamycin, and the pentaene filipin appear brownish-yellow, 
while heptaenes, like amphotericin B, appear dark yellow (Thomas, 1976). The 
chromophore is responsible for the interaction between polyenes and ergosterol, which 
is the primary fungal cell membrane sterol. Through the affinity of the chromophore 
towards ergosterol, polyene antibiotics invade the cell membrane. This interaction is 
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essential to the antimycotic properties of these antibiotics. (Ciesielski et al., 2016) 
Polyenes with more conjugated double bonds have greater affinity towards ergosterol 
than cholesterol and, therefore, higher biological activity and lower toxicity (Aszalos et 
al., 1985). However, polyenes with larger chromophores are more hydrophobic, which 
limits their dissemination throughout the aqueous portions of body (Thomas, 1976). 
"  
Figure 2: Spectra of a tetraene (A) and two heptaenes (B and C) (Thomas, 1976). 
Polyenes have comparably poor solubility in organic solvents due to the hydrophilic 
polyhydroxylated region or polyol chain. The polyol chain is located opposite to the 
chromophore on the macrolactone ring and may contain an epoxide group, carbonyl 
groups, and several hydroxyl groups. Carboxylic acid is generally one of the carbonyl 
groups; it exists as a zwitterion if the polyene possesses an amino sugar. (Thomas, 1976; 
Hamill, 2013) The amino sugar is usually mycosamine, but it can be perosamine. Sugars 
are linked to the carbon adjacent to the chromophore three carbons away from the 
carboxylic acid. Only glycosylated polyenes are in clinical use, since the polar nature of 
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the amino sugar group greatly improves solubility in water and the affinity of the drugs 
for ergosterol over cholesterol. (Zotchev, 2003; Kong et al., 2013) 
1.3 Polyene Antibiotics in Clinical Use 
While over 200 unique polyene macrolides with antifungal activity have been isolated 
from Streptomyces and other actinomycetes since the first was discovered in 1950, only 
a fraction are suitable for clinical use (Figure 3) (Zotchev et al., 2003). Polyene 
macrolides are among the most toxic compounds used in modern medicine; lethal side 
effects often limit dosage and therapy duration (Janout et al., 2015). Poor solubility in 
vivo causes drug toxicity and greatly limits drug dispersal to all niches of the body. 
Intravenous administration is necessary for treatment of systemic fungal infections, but 
oral and topical administration are effective for treatment of superficial thrush. (Santos-
Aberturas et al., 2015; Lyu et al., 2016) 
Polyene antibiotics have a broad spectrum of activity toward fungi, and a mechanism of 
action that is refractory to the evolution of resistance. They are the only class of 
antifungals to act from the cell exterior by directly targeting membrane sterols. Rates of 
acquired resistance remain low after decades of monotherapy treatments. (Kong et al., 
2013; Vincent et al., 2013) Polyenes will remain an indispensable therapeutic option. 
Resistance to all other classes of antifungal drugs arises soon after they are introduced 
into clinical practice. (Cannon et al., 2007; Walker et al., 2010) Nevertheless, there is 
great demand for polyenes with improved therapeutic activity, greater in vivo solubility 
and reduced toxicity (Cao et al., 2012). The most commonly used and well studied 
polyene macrolides include amphotericin B (AmB), nystatin, natamycin (pimaricin) and 
filipin  III (Figures 3 and 4) (Caffrey et al., 2016). 
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Figure 3: Structures of  glycosylated polyene macrolides natamycin (A), nystatin (B) and 
amphotericin B (C). Figure altered from Thomas (1976).  
1.3.1 Amphotericin B 
Amphotericin B (AmB) (Figure 3C) was first isolated from Streptomyces nodosus in 











for treating life threatening systemic fungal infections since 1957. (Gupte et al., 2002) It 
is a glycosylated heptaene and the third most used antifungal drug (Vincent et al., 2013). 
AmB has been used as a model for studying polyenes, as it remains the only polyene 
macrolide suited for effective treatment of deep-seated fungal infections. The drug has 
potent antifungal activity, it is broad spectrum and active against fungi which have 
developed resistance to other clinical drugs. Often, AmB becomes the last treatment 
option for systemic mycoses. (Baginski et al., 2005; Malayeri et al., 2018) It is the only 
treatment option during pregnancy because it is not teratogenic (Johnson et al., 2018).  
Despite clinical use world-wide as a monotherapy, resistance to AmB remains rare, and 
resistant strains do not persist. The decreased fitness and virulence of AmB-resistant 
fungi causes them to be outcompeted by native strains once antibiotic stress is removed. 
(Gray et al., 2012; Vincent et al., 2013) However, systemic fungal infections are still a 
serious health concern because AmB dosage and treatment duration are limited by 
equally concerning side effects (Wasko et al., 2012). Nephrotoxicity is the most cited 
concern, but there is also evidence that AmB alters the cellular composition of the blood, 
as anemia, thrombocytopenia and agranulocytosis follow AmB therapy. Side effects are 
primarily caused by the formation of drug aggregates in vivo which do not have the 
same selective toxicity as AmB monomers. The continued use of AmB makes apparent 
the lack of efficacious alternatives. (Lemke et al., 2005; Janout et al., 2015) 
1.3.2 Nystatin 
Nystatin (Figure 3B), initially called fungicidin, was discovered in 1950 from 
Streptomyces noursei (Hazen & Brown, 1950). It is a glycosylated polyene closely 
related to AmB, but it is classified as a tetraene or a degenerated heptaene because the 
chromophore is interrupted by a saturated bond (Romero et al., 2009). Nystatin has 
fungicidal activity against species of Candida, Aspergillus, Histoplasma and 
Coccidioides, including isolates resistant to AmB. However, its poor aqueous solubility 
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and formation of nonselective toxic aggregates in vivo preclude its use as a treatment for 
systemic mycoses. (Malayeri et al., 2018) 
Nystatin is applied as a cream or used as a mouth wash to treat superficial infections, or 
it is administered orally to treat gastrointestinal infections. In these applications, nystatin 
does not have side effects, since extreme hydrophobicity prevents absorption though the 
skin or gastrointestinal tract. Immunocompromised patients undergoing radiation 
therapy or chemotherapy at high risk of opportunity fungal infection are often prescribed 
nystatin as a prophylactic. The drug prevents Candida from adhering to epithelial cells. 
Despite widespread use, there are no reported cases of resistance to nystatin. (Scheibler 
et al., 2017) 
1.3.3 Natamycin 
Natamycin (Figure 3A), or pimaricin, is a small-sized glycosylated tetraene first isolated 
in 1955 from Streptomyces natalensis (Malayeri et al., 2018). The fungicidal potency 
and small size of this drug relative to other polyenes provoked extensive investigation 
into its mechanism of action, which has improved understanding of the function of all 
polyenes (te Welscher et al., 2008).  
Natamycin is both colorless and odorless and is therefore an ideal preservative to inhibit 
fungal growth in cheeses, sausages, yogurts and wines. It has been used in the food 
industry for over thirty years. The surface treatment of cheeses and sausages with 
natamycin is considered safe, since ultraviolet light degrades natamycin on the products 
by the time of consumption. Similar to other polyenes, natamycin is too hydrophobic to 
be absorbed through the gastrointestinal lining, so there is small risk of side effects. 
However, there is mounting concern that continual consumption of the drug in yogurts 
and wines will give rise to polyene-resistant fungi. (Paseiro-Cerrato et al., 2013; Dalhoff 
& Levy, 2015)  
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Medically, natamycin is most prominently used as eyedrops to treat ophthalmic 
mycoses. It is most effective against infections caused by Aspergillus or Fusarium, and 
it is the primary treatment for fungal keratitis. (Aparicio et al., 2016)  Natamycin is also 
used as a cream to cure topical infections caused by a great variety of fungi and some 
protozoa (Ciesielski et al., 2016).  
1.3.4 Filipin 
Filipin (Figure 4) is a complex of uncharged pentaenes with strong antifungal properties; 
it is produced by various strains of Streptomyces (Caffrey et al., 2008). Upon interaction 
with a cell membrane, filipin forms large complexes with sterols in the hydrophobic 
membrane interior and causes gross fragmentation. Unlike most known polyenes, it is 
non-glycosylated and shows similar affinity toward both cholesterol and ergosterol. 
(Zotchev, 2003; te Welscher et al., 2008)  
Filipin is too toxic to be used in human therapy because it is not sufficiently selective for 
ergosterol containing membranes. Instead, it is used as a means to determine the 
cholesterol content of membranes and as a reference for studies on the biosynthesis and 
activity of other polyene macrolides. It is used clinically to diagnose some metabolic 
disorders. Filipin is produced as four related variants, known as the filipin complex. 
Each variant in the filipin complex differs in the number of hydroxyl functional groups 
present. Filipin III is the major product. Filipin II is the second most prevalent, and it is 
a biosynthetic precursor to filipin III. (Payero et al., 2015) 
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Figure 4: The structures of the compounds in the filipin complex. Filipin III is the final 
major product in the complex. Figure altered from Payero et al., 2015.  
1.4 Antifungal Activity of Polyene Antibiotics 
Glycosylated polyene macrolides have multiple antifungal modes of action, which have 
been investigated since the discovery of the compounds in the 1950s. All of the known 
mechanisms involve an interaction between polyenes and ergosterol molecules in either 
the fungal cell membrane or the mitochondrial membrane. (Caffrey et al., 2016) The 
various details and effects of the interactions are not completely understood, but what 
has been elucidated will be discussed in coming section.  
Some polyene macrolides form ion pores in the cellular membrane through complex 
associations with membrane sterols to cause leakage of cell components, while others 
aggregate on the membrane surface to sequester ergosterol and disrupt ergosterol 
dependent cell processes (Caffrey et al., 2016). A more recent series of research points 
to the ability of polyene macrolides to induce oxidative damage in fungal cells through 
action at the mitochondrial membrane (Sangalli-Leite et al., 2011; Mesa-Arango et al., 
2014; Shekova et al., 2017). Regardless, fungal cell death caused by polyenes is a long-
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term, multistage event where interconnected pathways shut down due to an interaction 
of the drugs with ergosterol (Chudzik et al., 2015). 
1.4.1 Membrane Permeabilization 
"   
Figure 5: Cross-section of the transmembrane pore formed by amphotericin B in a 
fungal cell membrane. The polyol and chromophore regions are represented by the 
spheres and dashes, respectively (Zotchev, 2003). 
Permeabilization of the fungal cell membrane is the earliest and most well known model 
of polyene macrolide activity. In this model, 3 to 17 polyene molecules bind to an equal 
amount of ergosterol molecules to form hydrophilic pores in the cell membrane. For 
AmB, the pore is a complex of eight AmB molecules stacked with eight ergosterol to 
form a barrel. The AmB is oriented with the hydrophobic chromophores facing outwards 
towards the fatty-acid tails of the membrane and the hydrophilic polyol chains facing the 
interior (Figure 5). (Zotchev, 2003; Janout et al., 2015) The hydrophilic nature of the 
pore interior allows intracellular ions, such as K+, Na+ and Mg2+, to efflux to the 
hypotonic cell exterior. The electric potential that is created across the membrane by the 
efflux of the cations then causes hydrogen atoms to influx through the same pores. 
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Increasing the concentration of H+ results in acidification and eventual precipitation of 
components of the fungal cell cytoplasm. (Hamill, 2013) 
1.4.2 Formation of the Membrane Pore 
The formation and stability of the membrane pores formed by polyene macrolides have 
been studied using AmB as a model drug. Dimers and larger aggregates of AmB form in 
aqueous solutions at any pH via hydrophobic interactions between the chromophores. It 
is suspected that AmB molecules orient antiparallel to one another in intermolecular 
interactions because aggregate formation is not inhibited in basic aqueous solutions. At 
pH 12, the amino sugar protonates and the molecular charge becomes neutral. 
Electrostatic repulsion between the anionic carboxylic acid groups would otherwise 
inhibit aggregate formation in basic solutions. (Wasko et al., 2012) The aggregates 
resulting from the limited solubility of polyenes in water are important for eventual 
membrane pore formation, since many AmB molecules must be in the same location to 
form a membrane spanning pore (Zotchev, 2003; Tutaj et al., 2015).  
Dimers and aggregates of AmB initially attach to the fungal cell membrane via 
hydrogen bond formation between the amino groups of the mycosamine sugars and the 
phosphate groups of the membrane phospholipids. The AmB aggregates are 
perpendicular to the membrane surface with their chromophores interacting and their 
polyol regions facing outwards. This initial binding event will occur even if the 
membrane does not contain sterols. Further hydrogen bonding, between the outward 
facing polyol regions and the membrane phospholipid phosphate groups, pull apart the 
hydrophobic interactions between the chromophores. The exposed chromophores 
subsequently interact with the membrane phospholipid fatty acids and penetrate the 
outer surface of the cell membrane. (Zotchev, 2003; Romero et al., 2009; Cohen, 2010) 
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The polyol regions of the AmB molecules face toward each other and away from the cell 
interior in a V-shaped bowl. The hydrophobic ends of the molecules are held together 
via hydrogen bonding between the C35 hydroxyl groups. Membrane fluidity eventually 
causes the chromophore regions exposed to the membrane interior to interact with 
ergosterol or another sterol. Interaction with a sterol is essential for pulling the AmB 
molecules into the membrane to form a barrel, rather than a pocket. If no sterols are 
present in the membrane, the AmB pockets persist because of the low free energy at the 
membrane surface. (Romero et al., 2009; Cohen et al., 2010) 
After the AmB pocket forms a barrel perpendicular the membrane, the polar side of the 
macrolactone ring, which contains the carboxylic acid on C16 and the mycosamine 
sugar residue on C19, remains at the membrane surface (Figure 3C). The polyol regions 
of the AmB molecules in the complex interact with each other and form a hydrated pore. 
Hydrogen bonding between the carboxylic acid groups on C16 and the amino sugars on 
C19 of neighboring AmB molecules stabilize the pore. The membrane sterols in the 
complex fit between the AmB molecules in the barrel and interact with them via van der 
Waals forces. (Hartsel et al., 1993; Szpilman et al., 2008) Non-glycosylated polyenes 
can also form membrane pores, but pores without the stabilizing hydrogen bond 
between the carboxylic acid and amino sugar tend to be larger and less stable. 
Membrane fragmentation is common with non-glycosylated polyenes. (Zotchev, 2003) 
1.4.3 Proposed Amphotericin B Pore Conformations 
The length of an AmB molecule is 21Å, but cellular membranes are 43Å thick on 
average. This discrepancy has caused debate as to how AmB spans the entire membrane 
(Szpilman et al., 2008). Two models regarding how the pore spans the membrane have 
been proposed (Figure 6). In the first model, the membrane is pinched at the site of the 
pore, and a single barrel of AmB molecules spans the dimpled membrane. The C35 
hydroxyl groups are thought to maintain the dimple by hydrogen bonding with the 
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phosphate groups on the inner side of the cell membrane. (Gray et al., 2012) The 
presence of ergosterol and the hydrogen bonding between the polar heads of AmB and 
membrane phospholipids are important for stabilizing the membrane dimple in the 
single barrel model (Romero et al., 2009; Cohen 2010). 
"  
Figure 6: Single-barrel and double-barrel models of the amphotericin B pore. Hydrogen 
bonding between C35 -OH groups is indicated with dotted lines. The figure is altered 
from Szpilman et al. (2008). 
The double barrel pore model (Figure 6) is made up of two AmB barrel complexes 
linked tail-to-tail by hydrogen bonds between the C35 hydroxyl groups. The polar 
regions of the AmB barrels face the inner and outer membrane surfaces. (Szpilman et 
al., 2008; Gray et al., 2012) The double barrel model is supported by studies that have 
demonstrated that AmB has maximum ion conductance only when the drug is present on 
both sides of the membrane (Hartsel et al., 1993).  
The mechanism by which the inner membrane layer pore forms is not well understood, 
since the polar region of AmB should not cross the hydrophobic membrane interior by 
passive diffusion. It is hypothesized that membrane disruption caused by polyene 




membrane’s interior. Repulsion between the polar region of AmB and the membrane 
interior could result in some AmB molecules oriented with the polar heads on the inner 
membrane surface. Channel formation would occur as it did on the outer membrane 
surface. The channels starting from opposite sides of the membranes would eventually 
connect through hydrogen bonding between the C35 hydroxyl groups. (Hartsel et al., 
1993; Zotchev, 2003) Regardless of the pore model, the C35 hydroxyl group has been 
proven to be crucial for the formation of membrane spanning pores. AmB analogs with a 
methyl group at C35 instead of a hydroxyl group were unable to form electrolyte 
conducting channels in liposomes. (Szpilman et al., 2008) 
1.4.4 Types of Amphotericin B Pores 
Two different types of AmB membrane permeabilizing structures, called non-aqueous 
channels and aqueous pores (Figure 7), form depending on: the concentration of AmB, 
the availability of ergosterol and the prevalence of cholesterol in the cell membrane. The 
substrate specificities and contributions to cell death differ for the two structures. At 
first, non-aqueous channels, that do not include ergosterol, form. They are permeable to 
monovalent cations during short-lived open states, but impermeable to monovalent 
anions. Aqueous pores form when the AmB molecules in non-aqueous channels bind to 
ergosterol in the cell membrane. Stabilization from the sterols allows aqueous pores to 
span the entire membrane. Aqueous pores require more AmB and ergosterol to form, 
since AmB molecules must be in complex with ergosterol on each side of the 
membrane. The pores accommodate glucose, large electrolytes and monovalent anions 
and cations. (Cohen et al., 2010; Mesa-Arango et al., 2012)  
Pore formation occurs in milliseconds, but it is delayed in membranes containing only 
cholesterol (Mesa-Arango et al., 2012). The threshold concentration of AmB that must 
be reached for aqueous pores to form is mainly determined by the presence of ergosterol 
or cholesterol in the lipid membrane. Sterols are required to stabilize the membrane 
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spanning pore. Non-aqueous channels form at AmB concentrations of 0.05 x 10-6 M and 
0.5 x 10-6 M in membranes containing only ergosterol or only cholesterol, respectively. 
Aqueous channels form when AmB reaches concentrations of 0.4 x 10-6 M in 
membranes containing only ergosterol and 1.6–2.9 x 10-6 M in membranes containing 
only cholesterol. (Mouri et al., 2008) A greater concentration of AmB is required to form 
aqueous pores because the double-barrel pore model requires AmB on the intracellular 
membrane surface (Tutaj et al., 2015). 
"  
Figure 7: Non-aqueous channel (left) and aqueous pore (right). Aqueous pores form 
when non-aqueous channels complex with ergosterol. The aqueous pore is represented 
by a single-barrel model (Cohen, 2010).  
Permeability kinetics studies on the two membrane pore types were conducted by 
preparing liposomes from fungal cell plasma membranes. The liposomes were 
suspended in hyper-osmotic solutions of either urea or a nitrate salt. The effects of 
increasing AmB concentrations on liposome swelling were observed to determine 
whether the solutes were able to enter the liposomes through the AmB pores. At lesser 
concentrations of AmB, liposome swelling occurred only in the nitrate salt solution. 
Swelling was only observed in the urea solution after AmB reached a threshold 
concentration and aqueous pores formed. (Cohen 2010) 
It has been proven by using the K+ channel blocking compound tetraethylamonium 
(TEA), that the size of the AmB membrane channel increases with increasing AmB 
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concentration. TEA is a 4Å molecule, and ion permeability through non-aqueous 
channels is completely blocked by TEA until a threshold concentration of AmB is 
reached and aqueous pores can form. TEA is unable to block ion permeability through 
aqueous pores. These results suggest that the AmB aqueous pore has a diameter between 
4.5Å and 5Å. (Cohen, 2010) 
1.4.5 The Sequestration of Ergosterol 
Ergosterol sequestration (Figure 8) is a more recently accepted mechanism of polyene 
antifungal activity, and it was proven to be the primary fungicidal mechanism of action 
for AmB and natamycin (te Welscher et al., 2008; Palacios et al., 2011; Gray et al., 
2012; Anderson et al., 2014). Polyenes sitting on the outer surface of the cell membrane 
sequester ergosterol at the membrane surface. The drug-sterol complex either exists as a 
single layer or as large aggregates. These conformations, respectively, are the surface 
adsorption model and sterol sponge model of ergosterol sequestration. The overall 
decrease in ergosterol concentration within the cell disrupts processes that require 
ergosterol. Intracellular enzymes and membrane transporters need ergosterol to 
solubilize; alternative sterols are not effective replacements and cause additional stress 
to the cell. (Mesa-Arango et al., 2012; Caffrey et al., 2016) Additional effects of 
ergosterol sequestration are discussed in section 1.4.8. Ion channel formation is an 
important mechanism for polyene macrolide antibiotics, but it has been shown to be 
complementary to the effects of ergosterol sequestration (Gray et al., 2012).  
Membrane permeabilization and cell death are not always related. Filipin and natamycin 
cause minimal membrane leakage before cell death, while polyenes fungi-chromin and 
rimocidin incite strong K+ efflux, but are weakly fungicidal. Nystatin causes greater K+ 
efflux but is less cytotoxic than both AmB and an AmB methyl ester derivative. (Chen et 
al., 1978) The C16 carboxylic acid group in AmB methyl ester is converted to an ester, 
so the derivative cannot support membrane pores. AmB methyl ester is as cytotoxic as 
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native AmB at, but it has a slower killing rate than native AmB. (Gary-Bobo, 1989) The 
comparable toxicities of the membrane permeabilizing native AmB and non-
permeabilizing AmB methyl-ester suggest that membrane pore formation is a secondary 
mechanism for fungal cell death (Chen et al., 1978). 
"  
Figure 8: Surface adsorption (A) and Sterol Sponge (B) models of AmB ergosterol 
sequestration. AmB (grey) extracts ergosterol (red) from cells and sequesters it as the 
membrane surface as a single layer or as large aggregates (Janout et al., 2015). 
1.4.6 Mycosamine in Ergosterol Sequestration 
Gray et al. (2012) investigated the functional groups necessary for AmB to have 
antifungal activity. AmB derivatives with both the C35 hydroxyl group removed and the 
C16 carboxylic acid group changed to a methyl ester were tested for antifungal activity 
(Figure 9). Membrane pores were not formed by derivatives lacking the C35 hydroxyl 
group because intermolecular hydrogen bonds between C35 hydroxyl groups are critical 
for the formation of the AmB double barrel pore. The hydrogen bond from the C16 
carboxylic acid group also plays a role in pore stabilization, as well as in initial contact 
with membrane phosphate groups. Membrane pores were not possible as an antifungal 
mechanism with either of these derivatives. (Zotchev 2003; Szpilman et al., 2008; Gray 





Figure 9: Hydrogen bonding of the C16 carboxylic acid group (red) and C19 
mycosamine group (blue) on AmB with another AmB molecule, a membrane 
phospholipid and ergosterol. The figure is altered from Palacios et al. (2011). 
However, the non-permeabilizing AmB derivatives maintained potent antifungal 
activity. The mycosamine residue was unaltered in the derivatives and binding to 
ergosterol was not inhibited. Only derivatives with the C19 mycosamine sugar residue 
removed lacked antifungal activity. (Gray et al., 2012) The amino group on the 
mycosamine sugar plays a role in the initial hydrogen bonding between AmB and the 
phosphate groups on the cell membrane surface. The sugar residue also promotes the 
extraction of sterols from the membrane via hydrogen bonding between its amino group 
and the hydroxyl group on ergosterol. In addition, the amino group on the sugar residue 
stabilizes the membrane pore through hydrogen bonding with the C16 carboxylic acid 
group. (Palacios et al., 2011) 
1.4.7 The Sterol Sponge 
Anderson et al. (2014) demonstrated that the sterol sponge is the primary form of the 
AmB-ergosterol complex and the main mode of action for AmB (Figure 8B). Solid state 






membrane. Transmission electron microscopy images confirmed the NMR results; large 
aggregates of AmB and ergosterol were observed on the imaged membranes soon after 
AmB was added. (Anderson et al., 2014) It was confirmed that the extra-membranous 
aggregates extract ergosterol from the membrane by using imbedded spin labels to 
detect ergosterol in the membrane interior. Before AmB was added to the membranes, 
ergosterol NMR signals were shifted by the spin label probes within the membrane 
bilayer, but ergosterol signals were not shifted by the probes after AmB was added. 
Therefore, ergosterol occupies a position on the membrane surface when AmB is 
present. An in vivo test with yeast cells demonstrated that AmB that is pre-saturated with 
ergosterol is not cytotoxic to cells, even though the aggregates bound to living cells. 
(Anderson et al., 2014) 
1.4.8  Ergosterol Sequestration by Natamycin 
Evidence that the cytotoxic activity of polyenes does not rely on membrane 
permeabilization caused interest in the mechanisms of small polyenes. Natamycin, a 
small polyene, was initially hypothesized to have a mode of action unrelated to 
ergosterol, since it is unable to form pores. However, natamycin was the first polyene 
proven to kill yeast solely by binding to ergosterol. (te Welscher et al., 2008) Non-
permeabilizing AmB derivatives have antifungal activity comparable to that of 
natamycin (Gray et al., 2012). More natamycin binds to membranes containing 
ergosterol than membranes containing cholesterol. The minimal inhibitory concentration 
(MIC) of natamycin increases 15-fold against yeast engineered to primarily synthesize 
cholesterol. However, at no concentration does natamycin cause cation efflux in vivo or 
in vitro. (te Welscher et al., 2008) 
Natamycin sequesters ergosterol at the membrane surface by directly binding to it. 
However, large extracellular drug-sterol aggregates do not form (Figure 8A). In a 
subsequent study, te Welscher et al. (2010) investigated the effects of natamycin on the 
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membrane fission and fusion events in vacuolar transport. These dynamic events require 
membranes to reorganize into highly curved intermediate forms, stabilized by ergosterol 
(Burger, 2000). A saturating amount of natamycin inhibited 71% of vacuole fusion. 
Filipin and nystatin are more potent at saturating concentrations because, in addition to 
binding ergosterol, they cause membrane lysis. A staging assay determined that 
natamycin inhibits vacuole fusion at the priming phase when the membrane curve must 
be supported by ergosterol. (Peters et al., 2001; te Welscher et al., 2010) 
A later study by te Welscher et al. (2012) proved that the action of natamycin on 
ergosterol inhibits cell growth by stalling membrane transport proteins for amino acids 
and glucose. Membrane composition changes when ergosterol is sequestered, and 
transmembrane proteins become insoluble. Amino acid transport was blocked in a model 
fungi after incubation with natamycin. Glucose transport was also completely inhibited, 
but eventually recovered. Transcriptome analysis showed that the transporters were up-
regulated in a natamycin dose-dependent manner. However, only glucose transport 
recovered because expression of the sugar transporters was more than double that of the 
amino acid transporters. How quickly membrane transport resumes after natamycin 
stress is removed depends on the solubilities and expression levels of transport proteins. 
(Mesa-Arango et al., 2012; te Welscher et al., 2012) 
1.4.9 Induction of Oxidative Damage  
Sangalli-Leite et al. (2011) evaluated the effects of AmB on the encapsulated yeast 
Cryptococcus neoformans. Two cell viability tests provided paradoxical results. After 
incubation with AmB, no C. neoformans cells survived even though the cell membranes 
were intact. In a parallel XTT assay, which measures cell metabolism through the 
reduction of an indicator salt, more reduction occurred at higher concentrations of AmB. 
The results suggested that AmB induces oxidative damage to the cell cytoplasm without 
forming membrane pores. Further assays revealed that at MIC concentrations of AmB, 
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intracellular free radicals are produced and protein carbonylation occurs. (Sangalli-Leiti 
et al., 2011) The induction of oxidative damage subsequently causes cells to undergo 
apoptosis. Mature fungal biofilms are cleared in vivo by AmB induced apoptosis 
(Delattin et al., 2014).  
Cells treated with free radical scavengers before the addition of AmB show less 
evidence of intracellular oxidative damage (Mesa-Arango et al., 2012). It was proposed 
that AmB itself induces oxidation via the putative redox activity of the heptaene 
chromophore moiety (Hartsel et al., 1993; Sangalli-Leiti et al., 2011). This mechanism 
was disproven using synthetic AmB derivatives that were unable to bind ergosterol, but 
readily associated with lipid bilayers. Even though the heptaene chromophore was 
intact, the derivatives lacked antifungal activity. (Palacios et al., 2011) 
How AmB causes oxidative damage was investigated in multiple strains of pathogenic 
fungi. Reactive oxygen species (ROS) are natural byproducts of mitochondrial 
respiration, and they are required for AmB to cause oxidative damage. To lessen 
mitochondrial ROS content, rotenone, a toxin found in plants, was used to inhibit 
complex I of the electron transport chain. Fungal strains treated with rotenone before 
AmB treatment did not experience oxidative bursts and had significantly improved 
survivability. (Mesa-Arango et al., 2014) AmB causes extensive lipid oxidation at the 
mitochondria, which suggests that the oxidative burst occurs through disruption of the 
ergosterol containing mitochondrial membrane (Shekova et al., 2017).  
1.4.10 Oxidative Damage in Resistant Fungi 
The production of ROS and the oxidative burst were evaluated in AmB resistant fungi to 
understand the intracellular source of the radical species. ROS were not present in AmB 
resistant strains after treatment with the drug, and it was proposed that resistant strains 
produce fewer ROS. AmB resistant strains use alternative electron transfer and oxygen 
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reduction mechanisms that consume less molecular oxygen. Inhibition of the alternative 
oxidase decreased oxygen consumption in AmB resistant strains by more than 90%, 
indicating reliance on the alternative electron transfer mechanism. AmB resistant strains 
produce fewer ROS, and thereby lessen oxidative damage caused by lysis of the 
mitochondrial membrane. (Mesa-Arango et al., 2014; Shekova et al., 2017) 
The constitutive activity of heat shock protein 90 (Hsp90) in AmB resistant fungi further 
inhibits the oxidative burst. Hsp90 promotes a variety of stress response pathways, 
including antioxidant mechanisms. AmB resistant fungi use alternative sterols to which 
AmB cannot bind. However, the disruption of the ergosterol synthesis pathway produces 
ROS, as pathway intermediates accumulate and hazardous side reactions produce 
alternative sterols. (Vincent et al., 2013) There is no opportunity for a damaging 
oxidative burst when the stress response pathway is constitutively active. Catalase, a 
ROS-detoxifying enzyme, is continually expressed with 2.5 times greater frequency in 
AmB resistant fungi. (Mesa-Arango et al., 2014) 
1.5 Interactions & Toxicity of Polyenes 
Polyene macrolides can be used therapeutically to treat systemic fungal infections 
because they have a higher binding affinity with the ergosterol found in fungi than the 
cholesterol found in human cells (Zotchev, 2003; Umegawa et al., 2011). The toxicity of 
polyene antibiotics is mainly attributed to unwanted interactions with cholesterol. 
Although it has been shown that pore formation in membranes containing cholesterol 
requires higher concentrations of polyenes, toxicity still occurs in vivo due to the 
prevalence of polyene aggregates. (Mesa-Arango et al., 2012) 
The low aqueous solubility of polyenes causes them to aggregate through hydrophobic 
interactions between chromophores. High localized concentrations of polyenes lose 
selectivity for fungal pathogens; the drug aggregates are equally damaging towards host 
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cells. (Caffrey et al., 2016) Lysis of red blood cells by polyene aggregates, and the 
resulting anemia, is a major source of toxicity (Ciesielski et al., 2016). However, 
nephrotoxicity, which occurs as polyenes are filtered out of the blood by the kidneys, is 
the main dose-limiting side-effect that often requires antibiotic courses to be ended 
prematurely (Caffrey et al., 2008; Hamill 2013).  
1.5.1 Cholesterol and Ergosterol 
"  
Figure 10: Structures of cholesterol (left) and ergosterol (right) (Ciesielski et al., 2016). 
Cholesterol and ergosterol have only minor structural differences, which contribute to 
polyene selectivity for fungal membranes (Figure 10). Ergosterol has one additional 
double bond in the second ring, between carbons 7 and 8, and one in the tail chain, 
between carbons 22 and 23. The additional pi-bonds make the molecule more elongated 
and rigid than cholesterol. The greater rigidity and flatness of ergosterol allows for more 
stable electrostatic interactions with polyenes, and the two additional pi-bonds offer 
more opportunities for pi-stacking interactions with the polyene chromophore. (Hartsel 
et al., 1993; Umegawa et al., 2011) 
The differences in interaction strength between a polyene and ergosterol and a polyene 
and cholesterol is minor when single molecules are considered. However, multiple 
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polyene molecules must bind many sterols from a single cell to be cytotoxic. A 
cumulative effect from multiple polyene-sterol interactions results in polyene selective 
toxicity for fungal cells. Rates of sterol sponge and membrane pore formation are slower 
in cholesterol containing membranes. Single polyene molecules may bind cholesterol 
containing membranes transiently during treatment, but it is unlikely that enough AmB 
would bind to kill the effected human cell. (Baginski et al., 2002; Mouri et al., 2008) 
The use of alternative sterols, which are structurally similar to ergosterol, by AmB 
resistant strains corroborates the importance of minor structural differences in sterols 
with regard to polyene toxicity (te Welscher et al., 2008; Caffrey et al., 2016). However, 
this explanation of drug selectivity is only true when polyenes exist as single molecules 
in solution. Aggregates of polyenes are not selective for ergosterol. 
1.5.2 Attempts to Reduce Polyene Toxicity 
For polyene selectivity to persist in vivo, aggregate formation must be prevented 
(Szlinder-Richert et al., 2001). Containing AmB in liposomes allows for the gradual 
release of ergosterol-selective monomers. Lipid-based drug delivery systems have been 
shown to significantly reduce nephrotoxicity and improve survivability of AmB 
treatment by 28%. (Lemke et al., 2005) However, for regular treatments, these lipid 
formulations remain too expensive to manufacture (Caffrey et al., 2016).  
Semi-synthetic polyenes offer further opportunities to reduce toxicity. AmB molecules 
with the C16 carboxylic acid group converted to an ester are significantly less able to 
permeabilize cholesterol containing membranes than ergosterol containing membranes. 
An anionic carboxylic acid group stabilizes the positively charged mycosamine moiety 
in an orientation favorable for hydrogen bond formation with a sterol. (Gary-Bobo, 
1989) 
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AmB derivatives with a large molecular umbrella attached to the C16 carboxylic acid 
group are unable to form aggregates and retain antifungal activity comparable to the 
native drug (Figure 11). These derivatives do not form pores, and rely on the surface 
adsorption mechanism. Hemolytic activity and mammalian cytotoxicity were minimized 
in tests with the umbrella formulation. (Janout et al., 2015) Multiple other semi-
synthetic derivatives of AmB and other polyenes have been attempted, but they are often 
too difficult to synthesize for clinical application to be feasible. As a result, AmB has 
remained the only polyene suitable for systemic treatment without viable alternatives 
over the last 50 years. (Hamill, 2013; Caffrey et al., 2016) 
"  
Figure 11: Structure of an umbrella-tamed amphotericin B molecule formulated by 
Janout et al., 2015. The umbrella is attached to the C16 carboxylic acid group and 
prevents formation of molecular aggregates in aqueous solution. (Janout et al., 2015) 
1.5.3  
Polyene Interactions with Membranes 
A clear understanding of the interactions between polyenes and sterols is needed to 
guide the development of semi-synthetic polyene formulations. Solid state NMR is used 
to determine the relative binding affinities of polyenes for membrane components. 
C16
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Synthetic 1,2-di-oleoylphosphatidylcholine (DOPC) membranes that contain either 
ergosterol or cholesterol are incubated with either AmB or natamycin. Then, the 
attenuated NMR signals from the polyene-bound DOPC and sterols are compared to 
determine the relative binding affinities of polyenes for the membrane components. 
AmB preferentially interacts with ergosterol over DOPC in ergosterol containing 
liposomes. However, AmB has equal affinity toward cholesterol and DOPC in 
liposomes prepared with cholesterol. (Janout et al., 2015; Ciesielski et al., 2016) 
Synthetic membranes containing ergosterol more readily absorb AmB than cholesterol 
containing membranes (Kamiński et al., 2014). AmB profoundly affects membrane 
dynamics and the NMR signals of all membrane sterols and lipids. Carbon signals from 
the lipid chain tail region are particularly altered. This indicates that AmB inserts into 
the membrane. Natamycin, in contrast, specifically affects ergosterol and does not 
influence membrane dynamics or insert into the membrane. Natamycin also interacts 
with cholesterol, but interaction with DOPC is not apparent. (Ciesielski et al., 2016) 
1.5.4 Polyene Interactions with Sterols 
Comparisons between NMR spectra of membrane sterols in the presence and absence of 
polyenes enables assignment of the sterol carbons with which AmB and natamycin 
interact. In cholesterol, AmB causes signal attenuation mainly from carbons in the first 
and forth rings, but not in methyl groups 18 and 19 which are outside the plane of the 
core ring system (Figure 10). The exclusion of the non-planar methyl carbons and core 
rigidity of cholesterol in the presence of AmB suggests a planar interaction. Apart from 
the terminal carbons, the flexible tail region of cholesterol is unaffected by AmB. 
Natamycin has similar interactions with cholesterol in the first and forth rings. However, 
natamycin does interact with methyl groups 18 and 19, so it must bind to the other face 
of cholesterol. (Ciesielski et al., 2016) 
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AmB engages ergosterol along the ring structure and primarily dampens signals at the 
ridges between rings (Figure 12). A non-planar methyl group is engaged, indicating that 
AmB binds ergosterol on the side opposite to which it binds cholesterol. The ergosterol 
tail region is immobilized by the interaction, but the terminal chain carbons are not 
bound. The additional double bond in the ergosterol tail makes it more planar and better 
suited to bind to the rigid AmB structure. (Ciesielski et al., 2016) 
"   
Figure 12: The head-to-head interaction between AmB (blue) and ergosterol (red). 
(Ibrahim, 2013) 
A study on the orientation of the AmB-ergosterol complex confirmed that both head-to-
head and head-to-tail interactions occur between the two molecules. The head region in 
ergosterol has the hydroxyl group, and the head region in AmB contains the carboxylic 
acid and mycosamine residues. Head-to-head interactions between the polar regions 
occur more frequently. Head-to-tail interactions exist when ergosterol is in complex with 
many AmB molecules. In either pairing, the tail of ergosterol is in an extended 
conformation. (Umegawa et al., 2011) 
Natamycin attenuates far more ergosterol signals than it does cholesterol signals, 
including the terminal chain carbons which are forced to a position unfavorable for the 
tail (Ciesielski et al., 2016). The observed strong natamycin-ergosterol interactions 
explain the low toxicity of the drug in clinical use (Wang et al., 2018). 
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1.6 Microbial Resistance to Polyene Macrolides 
1.6.1 Treatment Options for Infectious Fungi  
Candida albicans is an opportunistic fungal pathogen with infection severity ranging 
from superficial thrush to invasive systemic mycoses. People with compromised 
immune systems as a result of cancer treatment, human immunodeficiency virus, or the 
immunosuppressive drugs that are given during organ transplants, are especially 
susceptible. (Sanglard et al., 2003) C. albicans is the most prevalent infectious fungi for 
humans and the fourth most common pathogen infecting hospital patients. Mild and life 
threatening systemic infections are initially treated with broad spectrum triazoles and 
echinocandin drugs, respectively. However, de novo resistance to triazoles arises 
frequently, and resistance to echinocandins is becoming more prevalent. (Walker et al., 
2010) If a systemic infection becomes resistant to both of these drug types, amphotericin 
B is the final treatment option (Vincent et al., 2013).  
Despite severe nephrotoxicity, poor solubility in vivo, and patient mortality rates of 
nearly 50%, AmB has been vital for treating systemic mycoses for over 50 years. It 
remains the third most used antifungal drug because fungal resistance arises extremely 
rarely in both clinical and laboratory settings. Theoretically, AmB resistant strains 
should be more common, since dose-limiting renal toxicity prevents complete regimens 
of AmB monotherapy, and poor penetration of AmB to all niches of the body fosters 
environments where resistance could evolve in vivo. (Thomas 1976; Anderson et al., 
2014; Caffrey et al., 2016) 
Analysis of 9,252 clinically isolated Candida species revealed that 99.8% were sensitive 
to AmB. It is rare for the utility of a widely used antibiotic to persist for so long. 5-
flucytosine was used for less than 20 years before it became obsolete, and the frequency 
of echinocandin resistance is steadily rising after just 17 years of clinical use. (Pfaller et 
al., 2012) The development of fungal resistance to nystatin is also rare, but systemic use 
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of the compound is not possible due to toxicity. The rarity of nystatin resistance is even 
more perplexing, as it is widely used as a long-term prophylactic topical agent for 
infants and immunocompromised patients (Gupte et al., 2002) 
1.6.2 Resisting Antifungal Drugs 
A study by Vincent et al. (2013) sought to elucidate why resistance to polyenes, and 
AmB specifically, is so rare. The group acquired AmB-resistant strains of C. albicans 
isolated from clinics and engineered resistant strains. The genomes of the resistant 
strains were sequenced to determine the mutations that confer AmB resistance; the 
ergosterol biosynthetic pathway was specifically considered. C. albicans clinical isolates 
most commonly resisted AmB via a double loss of function in ERG3 and ERG11, or by 
loss of function in either ERG2 or ERG6. (Sanglard et al., 2003; Vincent et al., 2013) 
ERG2, ERG3, ERG6 and ERG11 are the most relevant antifungal drug targets in the 
ergosterol biosynthetic pathway. These enzymes catalyze the tailoring reactions that 
convert lanosterol to ergosterol. Inhibiting any of the pathway enzymes prevents 
ergosterol biosynthesis and causes toxic sterol intermediates to accumulate. However, 
strains that resist the enzyme-targeting antifungal drugs are common. (Ghannoum & 
Rice, 1999; Sanglard et al., 2003) Minor mutations to the drug binding sites in the 
ergosterol biosynthetic enzymes confer resistance against antifungal drugs that target 
these enzymes by preventing drug binding. The minor mutations allow ergosterol 
biosynthesis to continue, and ergosterol is the functional sterol in strains resistant to the 
enzyme-targeting antifungal drugs. The inactivation of the tailoring enzymes to prevent 
ergosterol production is required in AmB resistant C. albicans mutants. The lack of 
ergosterol necessitates the use of alternative sterols, such as lanosterol, to which AmB 
cannot bind. (Anderson et al., 2014; Zhou et al., 2018) The hazards to fungi which resist 
polyene macrolides by stalling ergosterol biosynthesis are further explored in the 
following section. 
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1.6.3 Fitness Costs of Alternative Sterols in Resistant Strains 
Lanosterol is the first precursor in the ergosterol biosynthetic pathway after the 
cyclization of the common sterol precursor, squalene (Sanglard et al., 2003). While the 
use of lanosterol allows C. albicans to resist drugs that target ergosterol, there are 
significant costs to fitness because of the structural differences between lanosterol and 
ergosterol. Proteins in the membrane and cytoplasm rely on ergosterol to support proper 
structure and function. Lanosterol is an ineffective replacement; sterol-dependent 
proteins have reduced activity in AmB resistant strains of C. albicans. Pathogenicity is 
hampered in strains relying on lanosterol, and these strains are quickly cleared by the 
host’s immune system, should resistant strains arise in vivo. (Anderson et al., 2014) 
ERG3 and ERG11 double knockout mutants of C. albicans are avirulent in a mouse 
model and are unable to cause damage to human epithelial cells in vitro. While tissue 
invasion by the double knockout mutants is comparable to wild-type, the production of 
inflammatory cytokines and the presence of reactive oxygen species are greatly reduced. 
The ERG11 knockout mutants have increased sensitivity to reactive oxygen species. 
(Vincent et al., 2013; Zhou et al., 2018) 
Strains of C. albicans lacking ERG11 activity are unable to survive in aerobic 
environments unless ERG3 is also suppressed. This phenomenon is likely caused by 
additional stress from the disrupted ergosterol biosynthetic pathway. Since ERG11 is the 
first enzyme to act on lanosterol in wild-type fungi, lanosterol accumulates when 
ERG11 is inhibited. At elevated concentrations of lanosterol, other enzymes in the 
ergosterol pathway convert lanosterol to alternative sterols. (Sanglard et al., 2003) The 
activity of the other pathway enzymes causes toxic sterol intermediates and ROS to 
accumulate. Cell growth is slowed due to metabolic capacity being consumed by the 
constitutive activation of stress response pathways. (Cannon et al., 2007) 
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As mentioned in section 1.4.10, the abundance of toxic sterol intermediates and ROS 
make AmB resistant mutants dependent on Hsp90, which promotes stress response 
pathways. Hsp90 can be down regulated by 10-fold after stress in wild-type C. albicans 
to liberate cell resources for other processes. However, constitutive Hsp90 expression is 
necessary in AmB resistant strains, even in the absence of stressors from drugs or the 
host immune system. AmB resistant strains treated with Hsp90 inhibitors did not grow 
in vitro, and de novo emergence of resistant mutants was prevented by partially 
inhibiting Hsp90 function. (Vincent et al., 2013) 
The extreme dependence on Hsp90 activity creates possibilities for effective 
combination therapies using AmB and Hsp90 inhibitors. Combination therapies could 
reduce the required dosage of AmB and help to mitigate its severe toxicity, which has 
caused patient survival rates to remain near 50%. (Vincent et al., 2013) Development of 
this kind of combination therapy is important because virulent AmB resistant fungi 
could evolve. Fungi from the genus Penicillium produce and resist AmB without any 
effects on cell viability. Horizontal gene transfer from AmB producing strains to 
pathogenic fungi could give rise to polyene resistance that does not impact cell fitness 
(Svahn et al., 2015) 
Disruption of the ergosterol biosynthesis pathway is a detrimental strategy for fungi to 
resist polyene antibiotics. The inefficiency of sterol-dependent proteins and the 
prevalence of toxic sterol intermediates when C. albicans depends on lanosterol cause 
resistant strains to be outcompeted when selective pressure is removed. The constant 
activity of stress response pathways consumes cell resources and limits adaptability to 
adverse conditions; immunocompromised patients are able to survive AmB resistant C. 
albicans because the mutants are hypersensitive to fever. (Vincent et al., 2013) 
Other strategies of antibiotic resistance are not applicable to polyenes because they 
directly target the cell membrane via an interaction with ergosterol. This is paramount to 
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the continued utility of polyene antibiotics (Kong et al., 2013). The other drug targets in 
C. albicans are enzymes involve in RNA synthesis, ergosterol biosynthesis and cell wall 
biosynthesis. Enzyme targeting drugs can be resisted without dramatic cost to the cell. 
Drugs with intracellular targets can be resisted by increased expression of drug efflux 
pumps, destroying the drug, or over-expressing the drug target. The drug binding site on 
an enzyme can be mutated to prevent drug action without impeding enzyme activity. 
These resistance mechanisms do not hamper cell survivability and persist when 
antibiotic stress is removed. Drug destroying enzymes and efflux pumps can be 
regulated as needed, and enzymes with point mutations continue to be used. (Cannon et 
al., 2007) 
It is imperative for the continued utility of antibiotics that drug mechanisms of action are 
refractory to the evolution of antibiotic resistance. If resistance does arise, it should 
consume significant cell energy so that resistant strains are outcompeted by drug 
sensitive strains when stress is removed. Presently, polyene macrolides are the only class 
of antifungal drug to give rise to unstable resistant strains. (Vincent et al., 2013)  
1.7 Finding New Polyenes 
Streptomyces are collected from a diversity of biomes in the search for undiscovered 
compounds. A marked regression in the discovery of new compounds began in the 
1980s, and it has lead the search to increasingly remote and extreme environments, 
ranging from antarctic soils to tropical anthills. (Svahn et al., 2015; Van Arnam et al., 
2016) To determine if a species produces any compounds with medically advantageous 
bioactivity, a Streptomyces isolate is grown in different conditions, and culture extracts 
are screened for secondary metabolites (Liu et al., 2013).  
If a potentially interesting compound is found, the genome of the isolate is sequenced 
and exploited to improve production of the discovered compound. However, many 
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BGCs remain silent when Streptomyces are screened using standard laboratory methods 
because nutrient rich monocultures do not reflect the biological stresses of the natural 
environment. In the soil, innumerable microbes compete for limited resources; 
Streptomyces combat microbial competition via tightly regulated production of cytotoxic 
secondary metabolites. (Wezel & McDowall, 2011) Recent studies have shown that 
some BGCs may be switched on only when interspecies competition is introduced to 
laboratory culture conditions. Introducing microbial competition to Streptomyces 
cultivations may unveil new production potential in previously isolated strains. 
(Stubbendieck & Straight, 2016) 
A study by Nazari et al. (2013) analyzed changes in the gene expression of S. coelicolor 
when it was grown on agar or in soil cultures with and without chitin as a carbon source. 
Chitin is the second-most abundant polysaccharide by biomass in nature and is a major 
component of the fungal cell wall. The expression of 675 genes was significantly 
changed by the addition of chitin to cell cultures, and eight BGCs were induced. The 
gene cluster most prominently up-regulated in response to the chitin was a cryptic 
t1PKS; polyenes are one possible product from unidentified t1PKS gene clusters. 
(Nazari et al., 2013) Streptomyces are well adapted to regulate secondary metabolism in 
response to co-inhabiting competitors. Identifying how Streptomyces sense competition 
and regulate secondary metabolites can guide drug discovery when genetic information 
is available (Mendes et al., 2007).  
To date, all gene clusters encoding the enzymes that produce small-sized polyenes are 
known to contain a cholesterol oxidase encoding gene. The cholesterol oxidase enzyme 
serves as a fungal sensor and triggers antifungal production (Cao et al., 2012; Payero et 
al., 2015; Aparicio et al., 2016). Cholesterol oxidase catalyzes the first step in the 
degradation of natural sterols including cholesterol and ergosterol. In S. natalensis, 
cholesterol oxidase is required for the biosynthesis of natamycin. The location of the 
cholesterol oxidase gene, pimE, in the center of the natamycin gene cluster is indicative 
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of its role in natamycin production, but pimE is not a biosynthetic enzyme. Natamycin is 
not produced when pimE is knocked out, and production is restored by gene 
complementation or addition of PimE extract to knockout mutant cultures. Addition of 
cholesterol oxidases from different species to pimE knockout cultures also restores 
natamycin production. This indicates that the activity of cholesterol oxidase on a fungal 
cell component is involved in the function of the enzyme as a fungal sensor and positive 
regulator for the production of small-sized polyenes. (Antón et al., 2004; Mendes et al., 
2007; Aparicio & Martin, 2008) 
1.8 Introduction to the Current Work 
There is constant demand for new antibiotics with better selectivity and reduced toxicity. 
The three most used polyene macrolide antibiotics were all first used in the 1950s. 
While polyene resistant fungi continue to be rare, the primary polyenes in use are not 
ideal drugs. (Vincent et al., 2013) Only AmB is suitable for systemic treatment of deep-
seated mycoses, and its severe side-effects limit treatment success (Zotchev, 2003). 
Attempts to reduce the toxicity of existing polyenes by producing synthetic derivatives 
or developing slow-releasing formulations have been successful, but such approaches 
are too expensive or technically complicated for industrial scale production (Falk et al., 
1999; Lemke et al., 2005; Hamill, 2013). It is therefore sensible to continue searching 
for polyene antibiotics in natural sources. Most antibiotics were initially discovered by 
screening actinomycetes isolated from soil in the 1950s; this discovery platform has 
been nearly exhausted. Only the most obscure natural sources are likely to yield strains 
that produce novel compounds. (Lewis, 2013) 
However, a majority of Streptomyces screened in the past were grown in nutrient rich 
monocultures. Without the interspecies exchange of chemical signals, many BSGs 
would have remained silent during screening. Consequently, known strains have the 
potential to produce new compounds if the correct stimuli are introduced to cultures. 
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(Netzker et al., 2018) Genomic analysis determines which strains of Streptomyces 
should be further investigated using co-culture conditions (Bachmann et al., 2014). The 
search for new polyenes is guided by the knowledge that these compounds are produced 
by t1PKS gene clusters that contain a cholesterol oxidase gene. The cholesterol oxidase 
acts as a fungal sensor and enhances polyene production when fungi are present. 
(Aparicio et al., 2016) 
In the current work, four strains of Streptomyces were cultured with autoclaved baker’s 
yeast Saccharomyces cerevisiae to activate gene clusters predicted to produce polyenes. 
Crude extracts from the co-cultures were screened for polyenes using HPLC and MS. 
Three of the strains in the study were selected from the in-house strain collection based 
on available genome sequences. These strains each have a t1PKS cluster that contains a 
cholesterol oxidase.  
The forth Streptomyces studied, REDMBK6, was a soil isolate from a university 
laboratory course. The isolate produces two red compounds, RED2 and RED3, in 
transfer media only when it is grown with whole autoclaved yeast cells; yeast extract 
does not elicit production in transfer media. The compounds were produced in other 
media whether whole yeast was present or not. The red compounds were purified, and 
their structures were solved using NMR. Genome sequencing aided in identifying the 
two red compounds as metacycloprodigiosin and undecylprodigiosin. MS and NMR 
results verified the identity of the compounds. Compound extracts have antifungal 
activity against yeast, and the production profile of the REDMBK6 strain changes 
depending on the nitrogen source provided. 
!42
2 Aims: 
• Analyze the genomes in the in-house strain collection, and select Streptomyces with 
t1PKS gene clusters that contain a cholesterol oxidase encoding gene.  
• Determine the production conditions of the red compounds produced by the laboratory 
course isolate Streptomyces strain REDMBK6. 
• Grow the selected in house Streptomyces strains and REDMBK6 in media containing 
autoclaved whole yeast or yeast extract and compare the production profiles of the 
different cultivations using HPLC and MS. 
• Elucidate the chemical structures of the compounds produced only in the presence of 
whole yeast using NMR. 
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3 Material & Methods 
3.1 Strain Selection and Genome Mining 
The uncharacterized Streptomyces sp., REDMBK6, was isolated during a laboratory 
course and observed to produce red compounds. The strain was provided from the in-
house strain collection. 
The in-house Streptomyces genome collection was analyzed with Artemis genome 
browser (Carver et al., 2012) and AntiSMASH 4.1.0 (Blin et al., 2017) to identify strains 
that had t1PKS clusters containing cholesterol oxidase encoding genes. The strains 
selected for further investigation of polyene production were S. hygroscopicus JCM 
4712, S. peucetius ATCC 27952 and S. lavendulae BKMA 840. 
3.2 Cell Culturing and Production of Compounds 
REDMBK6 cultivations were either started with 250 µl of mycelia cell preparations 
stored in 20% glycerol at -80°C, or with spores produced on ISP4 plates (10 g/L starch, 
1.0 g/L K2HPO4, 1.0 g/L MgSO4 x 7 H2O, 1.0 g/L NaCl, 2.0 g/L (NH4)2SO4, 1.0 mL 
trace salt solution, 1.0 L distilled water. Trace salt solution contains 0.1 g FeSO4 • 7 
H2O, 0.1 g MnCl2 • 4 H2O, and 0.1 g ZnSO4 • 7 H2O in 100 mL of distilled water.  
REDMBK6 was grown in 250 mL Erlenmeyer flasks containing 25 mL media at 30°C 
with vigorous shaking for 3–5 days, depending on when the culture turned red. Transfer 
Media (10 g/L glucose, 1 g/L yeast or yeast extract, 1 g/L KNO3, 0.1 g/L K2HPO4) was 
initially used to investigate the influence of yeast on production. The yeast was store 
bought baker’s yeast, Saccharomyces cerevisiae. Russian yeast media (26 g/L whole 
yeast, 9 g/L glucose, 2 g/L CaCO3, 2 g/L NH4NO3, 1 L tap water) was subsequently used 
to investigate the influence of different nitrogen sources on the production of RED 
compounds. Whole yeast was replaced with equal amounts of malt extract, soy, or 
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casein derived amino acids. Yeast extract was used in control cultures. Mycelia were 
collected by centrifugation for 10 minutes at 3040 x g in a swing-out bucket rotor in 
small scale production. 
Russian yeast media was used in fermentations to produce large quantities of RED 
compounds. A 3L fermentation was inoculated with 50 mL of REDMBK6 preculture  in 
Russian yeast media. The fermentation continued for 5 days at 30°C with stirring and 
aeration. Streptomyces cultures were checked for contamination with light microscopy. 
Cells were collected from 3L fermentations by centrifugation for 20 minutes at 7025 x g 
with a JA-10 rotor. 
The strains predicted to produce polyenes were grown for 5 days at 30°C with vigorous 
shaking in 25 mL of Russian yeast media. The media contained either autoclaved 
baker’s yeast or yeast extract to determine whether gene cluster expression was altered 
by the presence of whole yeast cells. Cultures were inoculated with 250 µl of mycelial 
cell preparations in 20% glycerol stored at -80°C. 
3.3 Extraction of RED Compounds 
The RED compounds were extracted from centrifuged cell pellets with a 1:1:1 
methanol:toluene:0.1M phosphate buffer pH 7. Methanol was added first to lyse the 
cells and release the intracellular compounds. The methanol phase was then extracted 
with toluene, and the phosphate buffer was added to drive more of the hydrophobic 
RED compounds to the toluene phase. The toluene phase was subsequently extracted 
with phosphate buffer to remove cell membrane fats to the aqueous phase. The crude 
toluene extract was partially dried in vacuo at 77 bar and 40°C. The semi-dried extract 
was completely dried by nitrogen gas flow. 
!45
3.4 Extraction of Polyenes 
Cell cultures were collected by centrifuging for 10 minutes at 3040 x g in a swing-out 
bucket rotor. The supernatant was discarded, and the cell pellets were extracted with 5 
mL of methanol for 20 minutes at room temperature with gentle mixing. The samples 
were again centrifuged to separate cell debris from the crude extract. The supernatant 
was subsequently analyzed with analytical HPLC and LC-MS. 
3.5 Silica Chromatography for RED Compounds 
Dried RED compounds were re-solubilized in a minimal volume of 9:1 
chloroform:methanol solution and applied to a normal-phase silica chromatography 
column. The silica was from Sigma-Aldrich. Sodium sulfate was used to remove trace 
amounts of water from the solvents before chromatography. Fractions were collected as 
they eluted from the column. The fractions were dried in vacuo and analyzed with 
analytical HPLC.  
3.6  LH20 Chromatography for RED Compounds 
An LH20 size-exclusion column, from Sigma-Aldrich, was prepared by suspending the 
resin in methanol and adding it to a glass column. The resin bed was equilibrated with a 
constant flow of 3 column volumes of methanol. Dried RED2 and RED3 extracts were 
solubilized in a minimal volume of methanol and applied to the column. Fractions were 
collected as the compounds eluted and were analyzed with analytical HPLC.  
3.7 Analytical C18 HPLC  
RED compound extracts were solubilized in HPLC grade methanol for analytical HPLC. 
Buffer A was aqueous with 15% MeOH and 0.1% formic acid, and Buffer B was MeOH 
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with 0.1% formic acid. The flow rate was 0.5 mL/min. The running method is shown in 
Table 1.  
Crude methanol extracts from cells were screened for polyene production with 
analytical HPLC via the method shown in Table 2. Buffer A for the polyenes was 
aqueous with 15% acetonitrile and 0.1% formic acid, and Buffer B was acetonitrile. The 
flow rate was 0.5 mL/min.  
For all compounds, the HPLC instrument was a Shimadzu model SCL-10AVP, and the 
column was a Kinetex reverse-phase 2.6u C18 100Å; 100 x 4.6 mm from Phenomenex 
(537743-29). 
Table 1: Method for all HPLC and LC-MS runs in work with REDMBK6. 
Table 2: Method for all HPLC and LC-MS runs for discovery of polyenes. 
3.8 Preparative C18 HPLC 
Preparative HPLC was only run for the RED compounds. Dried silica chromatography 
fractions were re-solubilized in a minimal volume of 1:1 HPLC grade methanol and 
Mili-Q water. A 2 mL inoculation loop was filled with mili-Q water before a 1 mL 
injection of compound. Buffer A was aqueous with 15% MeOH and 0.1% formic acid, 
and Buffer B was 100% MeOH. The flow rate was 5.0 mL/min; the running method is 
shown in Table 1. The instrument was a Shimadzu model CBM-20A, and the column 
was a Sunfire: prep C18 5 µm 10 x 250 mm (column serial 163136081115 03). 
Time (min) 0 2 10 17 17.1 19 19.1 24
Buffer B 45% 45% 100% 100% 0% 0% 45% 45%
Time (min) 0 2 20 20.01 24 24.01 29
Buffer B 0% 0% 60% 100% 100% 0% 0%
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3.9 LC-MS  
The running conditions for the RED compounds on LC-MS were identical to those used 
for analytical HPLC; the method is shown in Table 1. The running conditions for 
analysis of crude polyene extracts with LC-MS were the same as those used for 
analytical HPLC, and the method is shown in Table 2. All compounds were solubilized 
in methanol for analysis. The column used for all samples was a Kinetex 2.6u C18 100A 
100 x 4.6 mm from Phenomenex (537743-29), and the instrument was an Agilent 1200 
HPLC with a Diode Array Detector. The compounds were ionized with electrospray 
ionization. 
3.10  High Resolution MS for RED Compounds 
Purified RED compounds were solubilized in methanol to determine exact masses with 
a Bruker Daltonics micrQTOF mass analyzer. The compounds were ionized with 
electrospray ionization and were analyzed in positive mode.   
3.11 NMR for RED Compounds 
Purified samples of RED2 and RED3 were prepared for NMR in deuterated methanol or 
deuterated chloroform, respectively. 1H NMR and 13C NMR 1D measurements, and 
COSY, HSQC-DE and HMBC 2D measurements were performed. The instruments used 
were a TYBruker600cryo with an actively shielded Bruker 600 MHz magnet, and an 
AABruker500cryo with an actively shielded Bruker 500 MHz magnet.  
3.12 Antibiotic Activity Assay  
Crude RED compounds or crude polyenes were solubilized in a minimal volume of 
chloroform and added drop-wise to a piece of filter paper. Excess chloroform was 
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evaporated in vacuo. Plain filter paper and filter paper soaked in chloroform were used 
as controls. Yeast was plated on a YPD plate (10 g/L yeast extract, 20 g/L peptone, 20 g/
L glucose, 15 g/L agar) and the compound-loaded paper was placed in the center of the 
plate. The yeast was allowed to grow at 30°C for 24 hrs, and a zone of inhibition was 
observed. 
3.13 Genomic DNA isolation  
REDMBK6 was cultured for 3 days at 30°C with vigorous shaking in 25 mL GYM 
media (4 g/L glucose, 4 g/L yeast extract, 10 g/L malt extract, 1L mili-Q water) to 
produce cells for DNA isolation. Cell culture was centrifuged for 10 minutes at 3040 x g 
in a swing-out bucket rotor to yield a pellet. Genomic DNA was isolated from the 
REDMBK6 cell pellet with the Salting Out procedure from Pospiech, A. and Neumann, 
B. (1995) and sent for sequencing. 
3.14 Spectrophotometry of RED2 at Varying pH Values 
The absorbance maxima of RED2 was determined by solubilizing samples purified with 
preparative HPLC in 0.1M phosphate buffers of varying pH. The pH values of the 
phosphate buffers were adjusted by gradually adding 1 molar HCl and 1 molar NaOH 
until the desired pH values were achieved. The phosphate buffers ranged from pH 3 to 
pH 9. A few drops of RED2 solubilized in MeOH was added to each buffer in a cuvette, 




4.1 Investigation of REDMBK6 
4.1.1 Production of RED Compounds 
The Streptomyces REDMBK6 was one of multiple strains isolated in a laboratory 
course. It was selected for further investigation because it produces RED2 and RED3 in 
transfer media only when whole yeast is used as a nitrogen source (Figure 13). The 
compounds are named based on when they elute from HPLC. These compounds were 
hypothesized to be polyene macrolide antibiotics, since production appeared to be 
dependent on the interaction between Streptomyces and intact yeast cells, and crude 
extracts had antifungal activity.  
"  
Figure 13: REDMBK6 production profiles in transfer media when whole yeast (red) and 
yeast extract (blue) are used as nitrogen sources. The chromatograms are shown at 530 
nm. RED3 was primarily produced in the cultivation grown with whole yeast.  
However, when media other than transfer media are used, REDMBK6 produces the 
compounds after 3 to 5 days of growth when cell density increases. Although the 
provided nitrogen source affects the ratio in which the compounds are produced, whole 
yeast cells are not necessary to elicit production in other media (Figure 14). REDMBK6 
never achieves high cell density when grown in transfer media, and cell growth is only 
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discernible as the media becomes cloudy. The compounds are not produced in transfer 
media without the additional cell density attributed by whole yeast in culture. 
"  
Figure 14: REDMBK6 production profiles in Russian yeast media when either whole 
yeast (red) or malt extract (blue) is used as a nitrogen source. Whole yeast causes RED2 
and RED3 to be produced in similar amounts, and malt extract elicits production of 
primarily RED3. The chromatograms are shown at 530 nm.  
RED2 and RED3 are produced in Russian yeast media after 3 to 5 days of growth, 
regardless of whether whole yeast is included in the culture. REDMBK6 cultures in 
Russian yeast media are dense with visible cell clusters in the media and cells collecting 
on the glass after 3 to 5 days. Compound production appears to be related to increased 
cell density. The compounds are produced in different ratios depending on the nitrogen 
source that is provided in Russian yeast media. Both compounds are produced in similar 
quantities when whole yeast is used, while malt extract elicits production of primarily 
RED3 (Figure 14). The compounds remain in the cells until they are extracted, and cell 




4.1.2 Spectral Properties of  the RED Compounds 
Extracts of RED2 and RED3 are red in neutral and acidic pH solutions and turn yellow 
in basic solutions. The absorbance maxima of purified RED2 were determined at 
varying pH values (Figure 15). Nitrogen was predicted to be present in the structure, 
since the color change is most dramatic between pH 5 and pH 6. Protonation and de-
protonation of nitrogen atoms that are part of a conjugated system cause color change. 
The compounds have similar absorbance maxima near 530 nm in acidic solutions 
(Figure 16). The absorbance maximum of RED2 is a slightly shorter wavelength than 
that of RED3 in acidic solutions. 
"  
Figure 15: The absorbance maxima of pure RED2 undergoes a hypsochromatic shift as 
the pH increases to basic conditions. The most dramatic color change is observed 
between pH 5 and pH 6. The color change is attributed to the influence of pH on the 
nitrogen atoms which are part of the conjugated system of RED2.  
Wavelength (nm)
350 375 400 425 450 475 500 525 550 575 600 625 650
pH3 pH4 pH5 pH6 pH9
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Figure 16: Absorbance maxima of RED2 (red) and RED3 (blue) in acidic conditions. 
The absorbance maximum of RED2 is a slightly shorter wavelength than RED3. The 
spectra were produced from a crude extract of the compounds analyzed with analytical 
HPLC in acidic conditions.  
4.1.3 Antifungal Activity of RED2 and RED3 
"  
Figure 17: Zone of inhibition in an S. cerevisiae culture created by a crude extract of 
RED2 and RED3 after 24hrs incubation at 30°C. The filter paper was loaded with 
compounds solubilized in chloroform, then dried and applied to the plate at the time of 
inoculation. A control using filter paper soaked in pure chloroform had no activity. 
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Crude extract from a culture of REDMBK6 grown in Russian yeast media with whole 
yeast was solubilized in chloroform and loaded drop-wise onto a piece of filter paper. 
The dried filter paper was placed on a freshly inoculated YPD plate of S. cerevisiae. A 
zone of inhibition was observed after a 24 hour incubation at 30°C (Figure 17). A 
negative control was carried out using filter paper that was soaked in pure chloroform 
and then dried. A zone of inhibition did not result in the negative control, indicating that 
the antifungal activity resulted from the crude RED compound extract.  
4.1.4 Structure Elucidation of RED2 and RED3 with NMR 
RED2 and RED3 were purified using multiple two-phase organic extractions and 
chromatography techniques to produce samples suitable for analysis with NMR. RED2 
was identified as metacycloprodigiosin, and RED3 was identified as undecylprodigiosin. 
The published structures are included as a reference (Figure 18) (Liu et al., 2005). 
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Figure 18: Published structures of metacycloprodigiosin or RED2 (A) and 
undecylprodigiosin or RED3 (B) (Liu et al., 2005). 
The one dimensional (1D) 1H NMR spectra of RED2 and RED3 show that the 
compounds have many aliphatic hydrogens with overlapping signals. The aliphatic 




(Figure 19). The coupling constants for the aliphatic hydrogens in RED2 could not be 
reliably discerned from the overlapping multiplets. The proximity of the signals is due to 
the hydrogens being in a similar chemical environment in the aliphatic ring structure 
(Figure 18A).  
"  
Figure 19: Aliphatic region of the 1H NMR spectrum RED2 (A) in deuterated methanol 
and  RED3 (B) in deuterated chloroform. The integrals indicate RED2 has 22 aliphatic 
hydrogens while RED3 has 23 aliphatic hydrogens. Integration was important for 
determining the number of hydrogen atoms represented by the overlapping multiplets. 
The large peak in the RED3 proton spectrum represents the 18 hydrogen atoms on the 
open chain of nine CH2 carbon atoms (Figure 19B). The hydrogens in the chain have 
nearly identical chemical shifts due to the free rotation around the carbon—carbon 






each compound has a triplet at 0.88 ppm with an integral of 3. This signal represents the 
3 hydrogens at the end of the aliphatic carbon chain in each compound (Figure 18B). 
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Figure 20: Aromatic region of the 1H NMR spectrum of RED2 (A) in deuterated 
methanol and RED3 (B) in deuterated chloroform. The integrals indicate 6 aromatic 
hydrogens for RED2 and 7 for RED3. The signal in A at 7.1 ppm represents two 
hydrogens with overlapping signals. The largest singlet in B at 7.25 ppm is caused by 
chloroform. 
The signals in the aromatic regions for each compound are fewer and less intense than 
the aliphatic signals (Figure 20). Hydrogen atoms on the rigid aromatic rings are further 
apart and in different chemical environments due to the rigidity of the aromatic rings. 
The aromatic signals are primarily singlets, since neighboring carbon atoms do not have 
hydrogen atoms bound. Two of the hydrogen signals in the aromatic region for RED2 




hydrogen atoms may be unfavorable for NMR. These signals are still considered to be 
part of the molecule because they have strong correlations with well defined parts of the 
molecule in the 2D NMR measurements. All of the aromatic hydrogen signals in RED3 
have integrals near 1 (Figure 20 B).  
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Figure 21: C13 NMR for RED2 (A) in deuterated methanol and RED3 (B) in deuterated 
chloroform. The largest peak in each spectra is from the solvent. Primarily aliphatic 
carbon atoms bound to hydrogen are visible in C13 NMR. Fully substituted and 
aromatic carbons give weaker signals. 
The C13 carbon spectra for the compounds give an indication of how many carbon 
atoms are in each compound (Figure 21). Differences between the spectra are due to the 






compounds have 28 carbons, although many quaternary carbon signals are too weak to 
be visible above the noise in the 1D measurements.  
Two dimensional (2D) spectra are used to determine the intramolecular interactions 
between all hydrogen and carbon atoms. Fully substituted and aromatic carbon atoms 
with weak signals that were indiscernible from background noise in the C13 
measurements were inferred by using HSQC-de and HMBC. Weak carbon signals that 
correlated with at least two hydrogens, which had integrals of at least 1, were considered 
to be legitimate carbon signals. HSQC-de shows which hydrogens are bound to which 
carbons and the hybridization state of the carbons (Figure 22). Blue signals in HSQC-de 
indicate a CH2 while green signals indicate either a CH or a CH3.  
The HSQC-de for the aliphatic region of RED2 shows many pairs of hydrogen atoms, 
which have different chemical shifts, bound to the same CH2 carbon. This phenomenon 
occurs in aliphatic rings because the two hydrogen atoms are held on different planes of 
the ring and interact differently with the magnetic field during NMR acquisition. The 
HSQC-de for RED3 has fewer signals because the aliphatic region has an open chain 
conformation where the atoms can rotate freely around the carbon—carbon sigma 
bonds. 
COSY 2D spectra show the interactions between the hydrogen atoms on neighboring 
carbon atoms (Figure 23). Unconnected fragments of the structure of RED2 were 
inferred by recognizing which hydrogen atoms interacted, and referencing HSQC-de to 
find the partnered carbon atoms. 1D hydrogen spectra are used as the reference in COSY 
spectra. The peaks in the diagonal line in every COSY spectrum results from the signal 
each hydrogen has for itself. A COSY signal indicating hydrogens on adjacent carbons 
was only considered valid if the signal was mirrored across the diagonal line. 
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Figure 22: HSQC-de 2D spectra for the aliphatic regions of RED2 (A) and RED3 (B). 
The x-axis shows hydrogen shift, the y-axis shows carbon shift. Blue signals represent 
CH2 groups and the green signals represents CH3 groups. Blue signals on the same Y-
plane indicate hydrogen atoms bound to the same carbon atom. HSQC-de is valuable 







Figure 23: COSY data for RED2 aliphatic (A) and aromatic (B) regions. Signals 
indicate relationships between hydrogen atoms on adjacent carbons. COSY is most 
valuable when the coupling constants for hydrogen signals are overlapping or singlets.  
HMBC signals represent interactions between a reference hydrogen and multiple distal 
carbons atoms (Figure 24). The distance of the carbons from the reference hydrogen 
varies depending on the structure of the molecule. In this study, carbons were at most 
three sigma bonds away from the reference hydrogen atom. HMBC was used to piece 
together the fragments of the molecules that become apparent with the COSY spectra. 
COSY measurements were crucial, since coupling constants could not be reliably 
determined for the crowded hydrogen signals in the aliphatic region (Figure 19). The 






HMBC data (Figure 25). Chemical shifts for the carbons and their associated hydrogens 
are given for RED2 in Table 3. 
!  
Figure 24: HMBC for the aliphatic (A) and aromatic (B) regions of RED2. Hydrogen 
spectra are on the x-axis and carbon spectra are on the y-axis. Signals indicate the 
interactions between hydrogens and distal carbons. Fully substituted carbon atoms with 
weak signals indiscernible from background noise are identified and verified as part of 






Table 3: 1H- and 13C-NMR data acquired for RED2 in deuterated methanol. Carbons in 
the rigid aliphatic ring have two hydrogens with different shifts. Numbering of carbons, 
as in Figure 25, is non-sequential due to nitrogens present in the structure. 
Carbon Number Carbon Shift (ppm) Hydrogen Shift (ppm)













1’ 30.16 2.79; 2.9
2’ 28.173 1.615; 1.845
3' 28.874 1.24; 1.46
4’ 26.855 0.24; 0.82
5’ 25.895 1.05; 1.34
6’ 23.947 0.961; 1.38
7’ 27.931 0.952; 1.09
8’ 35.433 1.45; 1.75
8 Ome 59.604 4.03
9’ 41.01 2.55




Figure 25: Structure of RED2 (metacycloprodigiosin) with NMR 2D spectral 
information drawn in. COSY relationships are in blue, and red arrows indicate HMBC. 
The green boxes indicate hydrogen atoms which had integrals smaller than 1. HMBC 
interactions were used to confirm that these hydrogen signals were genuine and were 
part of the structure. Only RED2 is shown since the NMR data for RED3 was analyzed 
by a colleague. Chemical shifts are written next to the corresponding carbons and 
hydrogens. This figure is altered from Liu et al., 2005. 
4.1.5 Masses of RED2 and RED3 
The exact masses were determined with high resolution MS in positive mode. RED3 has 
an exact mass of 393.2801 [394.2801 M+H]+ and RED2 has an exact mass of 391.2585 
[392.2585 M+H]+. RED3 is two mass units heavier than RED2, indicating two 
additional hydrogens in RED3 (Figure 26). The compounds were ultimately identified as 
metacycloprodigiosin (RED2) and undecylprodigiosin (RED3) when genetic 
information for REDMBK6 became available (Figure 27). RED3 has two additional 
hydrogens because its aliphatic carbon chain is open, and the molecule has one less 
carbon—carbon sigma bond.  
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Figure 26: Exact masses of RED2 [392.2585 M+H]+ and RED3 [394.2801 M+H]+ 
were determined by high resolution MS in positive mode. RED2 has two fewer 
hydrogens due to the cyclized aliphatic carbon chain.  
4.1.6 Biosynthetic Gene Cluster and Published Structures  
Genome sequencing of REDMBK6 revealed a biosynthetic gene cluster that was 
predicted to produce metacycloprodigiosin and undecylprodigiosin. These compounds 
match the elucidated structures of RED2 and RED3, respectively. AntiSMASH revealed 
a BGC from REDMBK6 that has 90% gene similarity to a known prodigiosin producing 
cluster (Blin et al., 2017). NMR data from this study was fit to the published structures 
and the accompanying NMR data from Liu et al. (2005). 
"  
Figure 27: Gene cluster for undecylprodigiosin in Streptomyces REDMBK6. The SARP 
family regulator is indicated. Core biosynthetic genes are red, other biosynthesis genes 
are pink, regulatory genes are green, and other genes are grey. The core biosynthetic 
genes primarily encode polyketide synthase enzymes. The regulatory genes encode a 







4.2 Activation of Polyene Gene Clusters 
4.2.1 Genome Mining  
Genome mining of the in-house strain collection revealed three strains which have 
t1PKS clusters containing a cholesterol oxidase encoding gene (Figure 28). These 
clusters are typical of polyene macrolides, and showed sequence similarity to BGCs 
known to produce polyene macrolides. The relevant clusters were found in JCM 4712 
and ATCC 27952 using the Artemis genome browser and AntiSMASH 4.1.0. The 
cholesterol oxidase gene within each cluster was identified by protein BLAST analysis 
(Camacho et al., 2009). Cholesterol oxidase was found in the BKMA 840 genome with 
Artemis, but the gene was not within a cluster identified by AntiSMASH 4.1.0. None of 
the clusters identified by AntiSMASH had more than 70% gene sequence similarity with 
a known compound. This degree of diversity is common amongst different polyene 
macrolide BGCs. (Carver et al., 2012; Blin et al., 2017) 
"  
Figure 28: The t1PKS gene clusters from JCM 4712 (top) and ATCC 27952 (bottom) 
suspected to produce the polyenes. Core biosynthetic genes are red, other biosynthesis 
genes are pink, regulatory genes are green and other genes are grey.  
4.2.2 Polyene Production 
The strains S. peucetius ATCC 27952, S. lavendulae BKMA 840 and S. hygroscopicus 
JCM 4712 produce multiple compounds in large quantities only when cultivated with 
whole yeast. Minimal amounts of the main products are visible on analytical HPLC in 
crude methanol extracts from cultures grown with yeast extract (Figures 29–31). The 
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main product from each strains is produced in at least ten-times greater quantities in 
cultures containing whole yeast than in cultures containing yeast extract. Crude extracts 
from all of the strains that produced polyenes appeared slightly yellow. Cultures with 
greater Streptomyces biomass produced the most compounds. The wavelength in all of 
the presented chromatograms is 358nm. This wavelength is an absorbance maximum for 
all of the major products from the analyzed strains and indicates that the products are 
pentaenes. The minor peaks are likely compounds at different stages in the biosynthesis 
of the major compounds, since they have the same absorbance maxima.  
"   
Figure 29: HPLC chromatograms of methanol extracts from ATCC 27952 at 358nm 
when grown with yeast (red) and without yeast (blue).  
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Figure 30: HPLC chromatograms of methanol extracts from BKMA 840 at 358nm when 
grown with yeast (red) and without yeast (blue). Major product peaks overlap. 
!  
Figure 31: HPLC chromatograms of methanol extracts from JCM 4712 at 358nm when 
grown with yeast (red) and without yeast (blue). 
4.2.3 Analysis of  Produced Compounds 
The major and minor compounds all have absorbance spectra maxima characteristic of 
polyene macrolides with three maxima peaks (Figure 32). The longest wavelength of the 
uv/vis absorbance maxima for all of the major products from co-cultures was 358 nm. 
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The other two uv/vis absorbance maxima for the major compounds are 338 nm and 322 
nm. Pentaenes have three uv/vis absorbance maxima between 300 nm and 400 nm 
(Thomas, 1976). Crude methanol extracts from mycelia appear slightly yellow when 
polyenes are present.  
"  
Figure 32: Absorbance spectrum of the main polyene product from BKMA 840 when 
grown in Russian yeast media containing whole yeast. Maxima are 358nm, 338nm and 
322nm. All products from the selected strains had similar uv/vis spectra. 
Crude extracts of the cultures grown with whole yeast have antifungal activity against S. 
cerevisiae grown on a YPD plate (Figure 33). After one day of growth at 30°C, a zone of 
inhibition, where yeast did not grow, was visible around the filter paper loaded with 
compound extract. Extracts from the whole yeast cultures were yellow when 
concentrated. The extract from the culture grown with yeast extract was clear, and no 
zone of inhibition was observed. Results from the negative control and the yeast extract 




Figure 33: Antibiotic activity assay with crude methanol extract from JCM 4712 mycelia 
grown without yeast (left) and with yeast (right). A zone of inhibition is visible around 
the filter paper loaded with extract from the JCM 4712 culture grown with whole yeast.  
4.2.4  Mass Spectrometry of Produced Compounds 
Crude methanol extracts from the three strains which produce polyenes when grown 
with whole yeast were analyzed with low resolution LC-MS (Figures 33–36). The 
wavelength used for all of the chromatograms was 358nm. The compounds did not 
ionize in positive mode, and all of the extracted ion masses are reported in negative 
mode. The masses of the major products which have an absorbance maximum at 358 nm 
were between 535 amu and 667 amu. Small-sized polyenes typically fall within this 
mass range (Thomas, 1976). ATCC 27952 and BKMA 840 produced larger compounds 
in lesser amount with masses of 926 amu and 1021 amu, respectively. 
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Figure 34: Absorbance shown at 358nm (top) and extracted ions (bottom) of the main 
products from ATCC 27952 cultured with yeast. The extracted ion masses in negative 
mode are 591 (blue), 605 (red), 607 (green), 621 (pink) and 925 (yellow).  
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Figure 35: Absorbance shown at 358nm (top) and extracted ions (bottom) of the main 
products from BKMA 840 cultured with yeast. The extracted ion masses in negative 
mode are 603 (blue), 635 (red), 651 (green) and 1020 (pink).  
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Figure 36: Absorbance shown at 358nm (top) and major products ionized in negative 
mode (bottom) from JCM 4712 cultured with yeast. The extracted ion masses in negative 
mode are 535 (blue), 635 (red) and 666 (green).  
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5 Discussion: 
5.1 Streptomyces REDMBK6 and the RED Compounds 
5.1.1 Identification of Metabolites from Streptomyces REDMBK6 
The laboratory course isolate Streptomyces REDMBK6 was singled out for additional 
analysis because it was observed to produce red colored compounds with antifungal 
activity only when it was grown with whole yeast. The bioactive compounds were 
believed to be polyenes, since the production appeared to be elicited by an interaction of 
the Streptomyces with a fungi (Mendes et al., 2007). However, the yeast-dependent 
production of the RED compounds was observed when REDMBK6 was cultured in 
transfer media. REDMBK6 never achieves a high cell density in transfer media, and the 
strain was eventually shown to produce the red compounds in Russian yeast media, 
regardless of whether yeast was included in the media. The implication of cell density 
on the regulation of the production of RED2 and RED3 is discussed in section 5.1.3.  
NMR analysis and genomic information on REDMBK6 were used to identify RED2 and 
RED3 as metacycloprodigiosin and undecylprodigiosin, respectively. The fragments of 
the structures that had been solved using HSQC-de, COSY and HMBC were assembled 
via comparison to the published structures as a guide (Figure 25). (Liu et al., 2005)  
Expectations that RED2 and RED3 were polyenes hampered structure elucidation. The 
HSQC-de signals from the aliphatic region of RED2 seemed to support the polyene 
macrolide hypothesis because they indicate a large ring structure (Figure 22A). In this 
region, each carbon has two hydrogen atoms which have different chemical shifts. The 
difference in hydrogen shifts is caused by how the hydrogen atoms held on opposite 
sides of the ring structure interact differently with the NMR magnetic field.  
!73
The proton spectrum of RED3 in Figure 19B has one main peak for 18 aliphatic 
hydrogens because the molecule has an open conformation, and the atoms can move 
freely around the sigma bonds. All of the interactions of these hydrogens with the 
magnetic field is on average equal, so equivalent chemical shifts result. The same is true 
for the carbon atoms in the aliphatic chain which all have chemical shifts of about 30 
ppm (Figure 21B). The similarity of the shifts for the hydrogens and carbons in the 
chain is clear in Figure 22B.   
5.1.2 Regulation of Undecylprodigiosin and Metacycloprodigiosin Production in  
         Streptomyces REDMBK6 
Undecylprodigiosin and metacycloprodigiosin are part of the prodigiosin family of 
compounds, and they have been described in multiple species of bacteria. 
Metacycloprodigiosin is one possible cyclized derivative. The role of these compounds 
in bacteria is not well understood, but general antimicrobial activity and UV protective 
properties benefit the producing microbe. Evidence suggests that undecylprodigiosin has 
anti-oxidative properties; producing cultures challenged with peroxides have better 
survivability. In addition, prodigiosins are antimalarial and immunosuppressive and 
have selective cytotoxic activity against breast cancer cells (Narva & Feitelson 1989; 
Stankovic et al., 2012). Undecylprodigiosin specifically has been shown to have potent 
anticancer activity against five cancer lines in vitro (Liu et al., 2005).  
Cell density or biomass dependent regulation for the production of RED2 and RED3 
explains the observations from the present study. Cultures of REDMBK6 grown in 
Russian yeast media began to produce compounds after 3 days of growth, regardless of 
whether whole yeast was present, because the cultures were dense. After three days in 
Russian yeast media, spheres of red colored mycelia were clearly visible, and 
Streptomyces began to collect on the edges of the flask. In transfer media, REDMBK6 
did not achieve high cell density; cell growth was only discernible as the media clouded. 
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Whole yeast cells were required in transfer media cultivations to add sufficient cell 
density and activate production of the RED compounds. It’s reasonable to conclude that 
a physical interaction between REDMBK6 and the yeast was necessary for production 
in transfer media, since yeast extract did not elicit production of any compounds (Figure 
13). Only the presence of additional biomass from a microbial competitor caused 
production of the RED compounds in transfer media. 
Biomass correlated production of prodigiosins has been previously described. 
Production begins late during culturing and compounds accumulate during the stationary 
phase of growth when cell mass is greatest. Low culture biomass correlates with lower 
compound yields (Stankovic et a., 2012). An undecylprodigiosin producing strain in 
which the cell division factor was over-expressed showed a 20 to 50 fold increase in 
production of the compound in a fermentor (van Wezel et al., 2006).  
Co-culture conditions have also been previously used to increase prodigiosin production 
in Streptomyces. S. lividans monocultures produced the red compounds after 3 days of 
culture and product concentrations increased until day 9 of cultivation. Four times more 
undecylprodigiosin was produced when S. lividans was co-cultured with Verticillium 
dahliae, but the authors did not report the time when production began in co-cultures. In 
addition, V. dahliae is a fungal pathogen that affects the roots of plants and causes 
vascular wilt world-wide. S. lividans significantly reduces the presence of the pathogen 
when introduced to plant roots infected with V. dahliae. The red compounds produced 
by S. lividans collected on and within the fungal hyphae, which subsequently withered. 
Undecylprodigiosin was the main product in the co-cultures. (Meschke et al., 2012) The 
production of prodigiosins has also been enhanced in S. coelicolor via the addition of 
sub-inhibitory concentrations of antibiotics to liquid culture (Wang et al., 2014). The 
Streptomyces begin to produce secondary metabolites when compounds from a 
competing species are detected. 
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Production of prodigiosins is regulated by the SARP family of regulators, which are 
growth-phase dependent. When cell density reaches a threshold and the regulatory 
pathway is activated, there is little downstream control. Production continues as long as 
precursors are available. (Narva & Feitelson 1989; Barka et al., 2016) A gene encoding a 
SARP family regulatory was identified with a standard protein BLAST on the regulatory 
genes identified by AntiSMASH (Figure 27) (Camacho et al., 2009; Blin et al., 2017).  
The production of prodigiosins in Streptomyces REDMBK6 is correlated with high cell 
culture density. The results indicate that it is not important whether the threshold cell 
density is achieved by Streptomyces growth or by adding autoclaved whole yeast cells to 
a culture with low cell density. Further investigation is required to determine whether 
the autoclaved yeast activates prodigiosin production because it adds biomass to culture, 
or because it is chemically detected by the Streptomyces. 
5.2 Production of Polyenes in Co-Culture Conditions 
5.2.1 Whole Yeast Cells Elicit Polyene Production 
The interaction between Streptomyces and fungi was exploited to incite the production 
of compounds from silent BGCs in well studied strains. Multiple unidentified polyene 
macrolides were produced by culturing three strains of Streptomyces with intact, 
autoclaved yeast cells. The strains were selected from the in house strain collection 
because they each have a t1PKS gene cluster that contains a cholesterol oxidase gene. 
All reported small-sized polyene macrolide gene clusters contain a cholesterol oxidase 
that functions as a fungal sensor and positive regulator (Aparicio et al., 2016). 
The small-sized polyene natamycin, or pimaricin, is not produced when the cholesterol 
oxidase gene is knocked out, but production is restored by adding cholesterol oxidase 
enzyme to Streptomyces culture. Sterols were discarded as a substrate that cholesterol 
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oxidase acts on in the natamycin signal transduction pathway. An unknown molecule is 
used to detect fungi and elicit production of natamycin (Mendes et al., 2007). Results 
from the current work suggest that the regulation in the tested strains is dependent on a 
physical interaction with the yeast cell membrane, as yeast extract did not elicit 
production of the polyenes (Figures 29–31).  
5.2.2 HPLC Analysis of Polyene Extracts 
HPLC analysis of crude extracts from cultures with comparable biomass show that 
significantly more compounds were produced when whole yeast was used as the 
nitrogen source. Each strain had at least one major compound accompanied by several 
minor peaks with varying retention times that were only present in cultures growth with 
whole yeast cells (Figures 29–31). The uv/vis spectrum of each co-culture product in all 
of the strains had three maxima, the most intense of which were 338 nm and 358 nm 
(Figure 32). The minor peaks are likely intermediate metabolites from various points of 
the biosynthesis of the final products because they also had uv/vis maxima of 338 nm 
and 358nm.  
The uv/vis spectra of polyene macrolides are dictated by the length and degree of 
conjugation in the chromophore region. Pentaenes, such as filipin, have three uv/vis 
maxima between 300nm and 400nm. The maxima shift to longer wavelengths in 
polyenes with a greater degree of conjugation in the chromophore. (Thomas 1976) The 
chromophore is synthesized before the macrolactone ring is closed and before 
subsequent oxidation and glycosylation reactions yield the final compound (Kong et al., 
2013). Chemical modifications in the final biosynthetic steps of the compounds would 
impact retention times with the C18 HPLC column employed, but the finishing steps 
would not influence the spectra. Therefore, the multiple minor peaks with identical uv/
vis spectra are likely biosynthetic intermediates of the major polyene products. 
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5.2.3 LC-MS Analysis of Crude Extracts 
LC-MS results revealed that each of the tested strains produces compounds that have 
masses between 536 g/mol and 667 g/mol when grown with whole yeast cells. This 
range is expected of small-sized polyenes whose BGCs contain a cholesterol oxidase 
encoding gene (Figures 33–36); cholesterol oxidase positively regulates polyene 
production in the presence of fungi (Aparicio & Martin, 2008). The BGCs for 
tetramycin and natamycin each contain a cholesterol oxidase, and the masses of these 
compounds are 695.8 g/mol and 665.7 g/mol, respectively (Cao et al., 2012).  
The major product from JCM 4712 with a mass of 667 g/mol could be natamycin 
(Paseiro-Cerrato et al., 2013). One of the other major products from JCM 4712 could be 
part of the filipin complex (636 g/mol) (Payero et al., 2015). The compound with mass 
536 g/mol produced by JCM 4712 is likely part of the biosynthetic pathway of a major 
polyene product. This compound is only present in cultivations where polyenes are 
produced (Figure 36). None of the aforementioned masses were present in extracts from 
yeast cells.  
BKMA 840 and ATCC 27952 produced filipin type compounds. Two of the major 
compounds produced by BKMA 840 had masses of 636 g/mol and 652 g/mol (Figure 
35). These compounds are each 2 mass units less than filipin II and filipin III, 
respectively. The filipin complex is composed of four different molecules, of which 
filipin II and filipin III are the major compounds. A loss of two mass units could be 
caused by the presence of an additional carbon—carbon bond. A compound with mass 
of 622 g/mol was identified in ATCC 27952. This mass corresponds to filipin I (622 g/
mol), which is a precursor to filipin III (654 g/mol) that has two fewer hydroxyl groups 
(Payero et al., 2015). The exact masses and identities of the discovered compounds 
cannot be certain, since they were not analyzed with high resolution MS. 
!78
In addition to small-sized polyenes, the strains produced other metabolites when grown 
with yeast. Larger masses were not anticipated, as the BGCs for large polyenes, those 
with masses over 800 g/mol, have not been reported to contain cholesterol oxidase. 
However, BKMA 840 had a major product with a mass of 1020 g/mol which was only 
produced when yeast was present in the culture. Because the production of this 
compound was associated with the presence of yeast, it is suspected to be an antifungal 
compound. No known polyenes with this mass could be found. ATCC 27952 produced a 
compound with a mass of 926 g/mol. The product from ATCC 27952 could be 
natamycin, which has a mass of 926.1 g/mol (Thomas 1976). 
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6 Conclusions: 
Streptomyces have an extensive secondary metabolism and complex regulatory network 
to effectively control the production of antimicrobial compounds critical for interspecies 
competition. It has become increasingly common to use co-culturing conditions to take 
advantage of the microbial interactions that naturally invoke expression of BGCs 
(Netzker et al., 2018). The current work has demonstrated that co-culturing 
Streptomyces with S. cerevisiae can activate the production of polyene macrolides in 
strains of Streptomyces that do not otherwise produce the compounds. The strains ATCC 
27952, BKMA 840 and JCM 4712 were selected based on genome mining of the in 
house strain collection for t1PKS clusters containing genes that encode cholesterol 
oxidase. REDMBK6 was selected because it was observed that culturing it with S. 
cerevisiae in transfer media elicited production of red compounds absent in monoculture 
conditions.  
The three Streptomyces strains selected based on genetic information all produced 
compounds hypothesized to be small-sized polyene macrolides based on spectral and 
mass data, as well as observed antifungal activity. Further work producing and purifying 
the compounds for NMR is required to definitively identify the products from the co-
cultures of Streptomyces and S. cerevisiae.  
The compounds produced by REDMBK6 when grown with yeast were identified as 
members of the prodigiosin family of compounds. The production of these compounds 
has been previously shown to be dependent on cell density and enhanced by the 
presence of competing fungi or sub-inhibitory concentrations of antibiotics (Meschek et 
al., 2012; Wang et al., 2014).  
Strain of Streptomyces may contain as many as 50 BGCs, each of which is capable of 
producing a natural product with potential clinical applications. A majority of the gene 
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clusters are unexpressed under the nutrient-rich, monoculture conditions, which have 
been the standard approach for compound discovery (Barka et al., 2016). As a result, the 
discovery of novel compounds has dramatically slowed in recent decades. A diversity of 
strategies for the discovery of novel compounds is required if clinical drugs are to 
remain effective against antibiotic resistant bacteria. Guided approaches utilizing 
genome mining and microbial-cross talk are becoming increasingly common and could 
bring about a second golden-age of compound discovery (Stubbendieck & Straight, 
2016; Netzker et al., 2018). 
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